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INTRODUCTION 
Ectopic Pregnancy is originated from ‘Ektopos’, a Greek word. In 
ectopic pregnancy the fertilized ovum implants outside the endometrial 
cavity of the uterus [1]. The most common extra uterine pregnancy is the 
tubal pregnancy in which a fertilized ovum implants in the fallopian 
tubes. Tubal pregnancies account for 98% of all ectopic gestations. Other 
sites like ovary, cervix, horn of the uterus, caesarean scar and abdominal 
cavity are rare [2].  
Incidence of ectopic pregnancy varies among different countries 
and also within the same country from place to place. The incidence is 
around 0.3 - 0.5% of deliveries in the U.S. and U.K, 4% of deliveries in 
Ghana and 2.1% of deliveries in Nigeria. [3,4,5]. 
In Shraddha Shetty K et al Study in India, the incidence was 5.6 / 
1000 deliveries[6]. In Rashmi Gaddagi et al study the incidence was 1:399 
pregnancies [7]. In a study conducted by Porwal Sanjay et al, the incidence 
was 2.46 / 1000 deliveries [8]. 
In current century, the developed countries are facing with four 
fold rise in the occurrence of ectopic pregnancy (from 0.3 to 1.2%) [9,10]. 
This rise is mainly because of advanced techniques for diagnosing the 
ectopic pregnancy in earlier stage and increased prevalence of ART & 
PID [11] [12]. 
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Ectopic pregnancy is a gynaecological emergency. In developing 
countries like India, late presentations with tubal rupture and 
haemodynamic instability are seen in most of the cases. In developing 
countries, ectopic pregnancy remains an important cause of first trimester 
maternal morbidity and mortality [13]. Fetal wastage, recurrence and 
impairment of subsequent fertility are the most important concerns [14]. 
Though maternal mortality has decreased and almost very rare 
nowadays, it has been reported by Arpita N et al that ectopic pregnancies 
account for 7.1% of all pregnancy related deaths in rural India [15]. The 
main causes of these deaths are due to wrong diagnosis, delayed 
diagnosis and late admissions with severe hypovolemic shock. Ruptured 
ectopic pregnancies with severe intra abdominal bleed may present with 
gastro intestinal symptoms like nausea, vomiting,   diarrhoea   and  poses  
a  great challenge in correct diagnosis [16]. 
The management of ectopic pregnancies has been revolutionized in 
developed countries, because of the availability of laparoscopic 
techniques, medical therapy, uterine artery ligation and more advanced 
diagnostic modalities which help in early diagnosis, better conservation 
of future fertility [17], shorter hospital stay & reduced surgical morbidity.  
Due to several factors like delay in seeking health care, absence of 
investigations (like hCG, progesterone assays, transvaginal sonography) 
and lack of suspicion in the diagnosis of ectopic of pregnancy by most of 
3 
 
the inexperienced clinicians, early diagnosis is almost impossible in most 
developing countries [18]. 
In developing countries, many studies have shown that the ectopic 
gestation case fatality rate was 1 % - 3%. This is 10 times more than the 
case fatality rates reported in developed countries [19].  
Although no risk factors have been identified in most of the cases 
with ectopic gestation, studies have highlighted that the awareness of risk 
factors associated with ectopic gestation helps in identifying the cases 
early [20] . Main risk factor is the prior tubal damage due to any cause [20].  
Chlamydial infection was  found  to  be  the  risk  factor for  30 - 50% of  
all  ectopic gestation  [21].  
Asymptomatic ectopic pregnancies are commonly seen in cases 
with early and unruptured ectopic gestation. When it ruptures symptoms 
could be acute or subacute [22]. Classical triad of ectopic pregnancy,  
 
 
 
 
 
occurs only in 50% of the cases [23]. Because of the atypical presentations, 
the diagnosis remains a challenge to the obstetricians & Gynaecologists. 
Ectopic gestation is an important cause of maternal morbidity, presenting 
Amenorrhoea 
Bleeding  P/V Abdominal Pain 
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with acute symptoms like pelvic pain, bleeding p/v and long term 
complications like infertility [24]. 
The incidence of rupture has declined in the last decades due to the 
availability of quantitative hCG assays, transvaginal sonography and 
minimally invasive surgeries [25]. 
Early diagnosis of ectopic pregnancy helps to reduce the incidence 
of rupture. So, the physician can provide conservative medical and 
surgical treatments [26]. 
Since, ectopic pregnancy is an important health problem among the 
reproductive age group women, the study was aimed to determine the 
clinical profile of the patients as well as the risk factors so as to make 
recommendations in order to reduce the incidence of this life threatening 
event.  
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JUSTIFICATION OF THE STUDY 
Ectopic pregnancy is an important cause of maternal morbidity & 
mortality in early pregnancy on the one hand, there is a high chance of 
inaccurate diagnosis on the other hand, clinician might be faced with 
severe problems like life threatening haemorrhage. A variety of 
therapeutic options are available but there are no standard guidelines 
regarding the ideal management. Conservation of future fertility has 
priority while severe haemorrhage also needs to be prevented.  
Ectopic pregnancy is a challenge for the clinician due to its bizarre 
clinical presentation. The diagnosis is complicated by the wide spectrum 
of presentations, from asymptomatic cases to acute abdomen and 
haemorrhagic shock.  
Its ambiguous presentation may mimic most of the surgical and 
gynaecological emergencies. 
The frequency of ectopic pregnancy has been increased during the 
last decades because of the increased incidence of sexually transmitted 
infections, advent of antibiotics, increased awareness and usage of 
various contraceptive methods and assisted reproductive technologies [27]. 
Prior damage to the fallopian tubes, resulting from previous ectopic 
pregnancy and previous tubal surgeries to relieve infertility or for 
sterilisation remains the highest risk factor for ectopic pregnancy [28]. 
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A greater understanding of the etiology, an accurate history taking 
and relevant physical examination and its correlation with diagnostic 
techniques is critical for the development of preventive measures, early 
diagnosis and the development of novel treatments [29]. 
In developed countries, the management of ectopic pregnancies has 
dramatically improved, with less radical procedures performed with 
laparoscopy and medical management being increasingly utilised [30]. 
This is possible because majority of the patients are diagnosed early with 
the use of high resolution USG and improved biochemical detection of 
beta hCG. However, in developing countries like India salphingectomy 
by laparotomy still remains the main stay of treatment as majority of our 
patients present with tubal rupture. This is due to lack of awareness, 
ignorance, poverty, lack of adequate health services and difficulty in 
transportation [31]. 
Ectopic pregnancy could be considered as a public health indicator 
in the developing world, because ectopic pregnancy presents as an acute 
emergency and it is a life threatening event, providing an overall picture 
of a health system capacity to handle with the diagnosis and management 
of emergency situations.  
Ectopic pregnancy is an emergency situation in which timely 
intervention will reduce the maternal mortality & morbidity. Clinical 
presentation varies from case to case and still there is a chance of missing 
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the diagnosis in a small proportion of patients even with the availability 
of advanced imaging techniques. For early diagnosis a clinician should be 
well aware about the various presentations of ectopic pregnancy. My 
study will provide a detailed clinical description on ectopic pregnancy.  
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AIM OF THE STUDY 
A detailed study on ectopic pregnancy over a particular time period 
in order to determine the incidence, risk factors, clinical features, 
diagnostic methods, treatments, morbidity and mortality associated with 
ectopic pregnancy in a tertiary care hospital and analysis of various 
aspects of ectopic pregnancy with a view to suggest interventions to join 
the global trend of early diagnosis and conservative management. 
OBJECTIVES  
1. To know the incidence of ectopic pregnancy.  
2. To know the age group, parity, sterilisation status with respect to 
ectopic pregnancy.  
3. To analyse the various risk factors associated with ectopic 
pregnancy.  
4. To describe the clinical presentation of ectopic pregnancy.  
5. To determine the sensitivity and specificity of amenorrhoea, 
abdominal pain and vaginal bleeding in diagnosing ectopic 
pregnancy among the suspected cases.  
6. To determine the positive and negative predictive values of 
amenorrhoea, lower abdominal pain and vaginal bleeding among 
the suspects.  
7. To determine the sensitivity & specificity of cervical excitation 
test. 
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8. To determine the sensitivity and specificity of UPT, culdocentesis 
& USG among the suspects.  
9. To determine the factors associated with time delay between 
admission & onset of treatment.  
10. To determine the factors associated with radical procedures over 
conservative management. 
11. To apply medical management criteria for all cases of unruptured 
ectopic pregnancy. 
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REVIEW OF LITERATURE 
Pathophysiology of ectopic pregnancy: 
Ectopic pregnancy is a significant problem for reproductive age 
women and their health care providers [32, 33]. An ectopic pregnancy 
results from disruption in the tubal transport process and ectopic 
pregnancy complicates 2% of all pregnancies in western countries[34]. 
More than 98% of ectopic gestations develop in the fallopian tube [35]. 
Unfortunately, there are no effective means of prevention, prediction or 
treatment of tubal implantation [35,36]. Despite the intense research 
activities, the basic pathology of tubal ectopic pregnancy remains a 
mystery [37, 38, 39]. This is in larger part due to our incomplete 
understanding of the complex molecular events behind muscle 
contraction, ciliary beating and tubal fluid micro environment changes 
during the gamete transport [39]. Disruption of any of these events results 
in abnormal interactions between the tubal cells & the early embryo and 
leads to tubal implantation [35]. 
The process of fertilization & earlier stages of embryonic 
development and implantation begins in the fallopian tube as a result of 
co-ordinated  biochemical and physiological steps[40] . Tubal implantation 
may results from functional and molecular aberrations in the fallopian 
tubes, improper tubal fluid environment or abnormal sex steroid 
responsiveness [41].. 
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Abnormal tubal transport  
Abnormal ciliary function or spasm in the muscular layer of the 
fallopian tube may arrest the forwarding movements of the fertilised 
ovum along the fallopian tube and may result in tubal ectopic pregnancy. 
Mechanical factors like congenital obstruction of the malformed fallopian 
tubes, local endocrine factors, emotional & psychosomatic problems and 
improper progesterone secretion are associated with abnormal tubal 
transport. Inadequate corpus luteal secretion of progesterone may be 
sufficient to disrupt the normal passage of an embryo along the fallopian 
tube (Hunter, 1988). The diameter of the sperm head is only 5-8 micron. 
But the oocyte is 100 micron in diameter. In a partially obstructed 
fallopian tube, sometimes sperms can pass through but the oocyte could 
not. This explains the occurrence of an ectopic pregnancy in the distal 
segment of  a partially obstructed tube. 
Tubal infections:  
Tubal infections, particularly chlamydial infection results in 
scarring of the fallopian tube and loss of patency (Sweet, 1982; Tuffrey et 
al., 1986). Tuberculosis and gonococcal infections may be involved in 
PID and complications at tubal level can arise following septic abortions. 
Inflammation arising from the bacterial infection leads to scarring of the 
fallopian tubes and results in partial or complete occlusion. Even if 
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patency has not been compromised seriously, the damage to endosalphinx 
results in surface alteration and favours ectopic implantation.  
Ectopic pregnancy after sterilisation may result from operator 
errors or factors independent of operator errors [42]. Operator errors 
include,  
1) Incorrect localisation of the sterilisation site. 
2) Deviation from the recommended technique. 
3) Failure to check the sterilisation method in a systematic way.  
4) Transection of the fallopian tube partially or completely.  
5) Application of  two clips  on  each tube.  
6) Improperly  maintained  mechanical occlusion device applicator.  
Factors other than that of operator errors include,  
1. Recanalisation of the tubes. 
2. Formation of tubo peritoneal fistula, which may results from 
necrosis, tubal atrophy or endosalphingiosis[42]. 
3. Spontaneous reapproximation of the ends of tubes associated with 
tubal reanastomosis & recanalisation [42]. 
4. Congenital malformations  like uterus didelphys, presence of an 
accessory fallopian tube and  pre -existing uterotubal fistulas [43] . 
Other factors like tubal healing response of the individual, extent of 
tubal avascularity,  pre - existing  proliferative tubal disease and the time 
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interval since operation are likely to affect  the ability of tubal lumen to 
regenerate. [44,45,46,47,48,49]. 
Role of luminal fluids: 
At the onset of implantation, the metabolic support to an 
developing embryo  is  fulfilled  by   
i) The  cytoplasmic  reserves  of  the oocyte .  
ii) Various nutrients in the luminal fluid and uterine fluid, particularly 
pyruvate, lactate and glucose ( Leese et al., 1988;Tay et al ., 1997).  
These fluids are of characteristic composition regulated by the 
ovarian steroid hormones and developing embryo’s metabolic 
requirements. The difference between tubal and uterine fluids are 
maintained by a formidable utero - tubal junction (Lee 1928; Flechon and 
Hunter, 1981). Glycoprotein secretions accumulating in the caudal 
portion of the isthmus also helps to maintain this difference. The tubal 
fluid also differs from region to region along and within the fallopian 
tubes (Leese, 1988, Nichol et al 1992). These factors help to maintain  the 
tubal  micro environment.  
In reality both flexibility in substrate requirements of the embryo 
and overlap in the composition of uterine and tubal fluids could underlie 
the occurrence of an ectopic gestation (Lee 1928; Patek, 1974; Hunter, 
1977, 1998). Infact, the development of an ectopic pregnancy at various 
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sites within the abdomen demonstrates the tolerance of the human 
embryo in the initial fluid environment.  
Cellular and molecular mechanisms: 
No biomarkers have been identified with high predictive value for 
tubal ectopic pregnancy [50] and the understanding of development of 
tubal ectopic pregnancy in humans at the cellular and molecular level is 
hampered by a lack of appropriate animal models [51]. 
17β estradiol, acting through estrogen receptors α & β may play a 
fundamental role in tubal cell homeostasis regulation and modulation of 
tubal physiological process. Fluctuations in the E2 level, E2 metabolism 
and the expression of estrogen receptor subtype in fallopian tube may 
play a crucial role in fallopian tube malfunction and development of  
ectopic pregnancy [52]. 
There is no animal model available for ectopic pregnancy, since it 
has not been reported in other organisms [53, 54]. Chlamydial infection is 
the main cause of ectopic pregnancy. So Chalmydial infection has been 
used in the mice to develop a model system for ectopic pregnancy. In this 
study, the muscle tone of the oviductal wall is reduced and the electrical 
pace maker potential which is required for the oviductal motility is lost 
[54, 55]. Thus tubal infection increases the incidence of ectopic pregnancy 
by impairing oviductal embryo transport. 
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Endocannabinoids, such as anandamide and 2-arachidonyl glycerol 
are ligands for cannabinoid receptor (CB1) and (CB2) [56]. Fatty Acid 
Amide hydrolase (FAAH) is an endocannabinoid degrading enzyme, 
which is important for maintaining the adequate levels of anandamide in 
the uterine environment. An increased risk of tubal pregnancy has been 
reported in recent studies using FAAH or CB-1 deficient mice caused by 
a delay in embryo transport from the oviductal  tube  to the uterus [53, 57]. 
Micro RNAs (mi RNAs), are evolutionarily conserved, small, non 
coding RNAs containing 21 to 24 nucleotides. They have emerged as 
overall gene expression regulators [58]. It has been reported that micro 
RNAs are expressed differentially in human fallopian tubes [59, 60]. 
Recently, the expression of several circulating mi RNAs have been 
shown as novel biomarkers for the diagnosis of tubal ectopic pregnancy.  
Despite the decades of research, there is still a crucial need for the 
comprehensive understanding of the underlying pathophysiology of tubal 
ectopic pregnancy that fully integrates cellular mechanisms, gene 
regulation and signalling pathways in the fallopian tubes [61]. 
Age  
Age has a role in the occurrence of ectopic pregnancy & other 
pregnancy complications. A study conducted by Bouyer et al proved that 
age has an important role and increases the exposure to other risk 
factors[62].. The progressive loss of myoelectrical activity along the 
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fallopian tube occurs due to aging. Age related changes in the tubal 
function and tubal diverticula predispose the older age group patients to 
develop ectopic pregnancy [63, 64].  
In India, many studies have shown that the peak age of ectopic 
pregnancy incidence was between 20 - 30 years. (Samiya mufti et al, 
Majhi AK et al) [65, 66]. Westorm in swedon 3 in 1981 and Rubin et al in 
USA reported an increasing occurrence of ectopic pregnancy with age [67, 
68]. Yuk JS et al showed that older age was associated with high 
occurrence of ectopic pregnancy in Korea [71].  This difference might be 
due to social factors. In India early marriage is common and most of the 
women finish their family before the age of 30 years. And also 20 - 30 
years is the most fertile period with infrequent usage of contraception.  
Parity 
There is also a relationship between the parity and the ectopic 
pregnancy risk. A study conducted in the department of general hospital 
‘George Gennimatas’ in Athense, Greece showed the statistically 
significant positive association between parity and ectopic pregnancy 
rupture [69]. Samiya Mufti et al.,Majhi et al., Smita Singh et al., showed 
the increased incidence of ectopic pregnancy in primigravida [65,66,70].  
Socio economic status  
Low socio economic status is associated with high incidence of 
ectopic pregnancy [71]. This may be due to increased prevalence of 
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sexually transmitted infections among the low socio economic group and 
their risky behaviour of delay in seeking health care facilities.  
Tubal sterilisation  
 When tubal sterilisation fails, the ectopic pregnancy is likely. The 
incidence of ectopic pregnancy after tubal sterilisation failure varies 
between 5-90% [72]. Tubal ligation with resultant tubal damage carries 
odds ratio of 9.3 for ectopic pregnancy in comparison with pregnant 
controls [73]. Tubal sterilisation is widely regarded as a highly effective 
method of contraception. In a large multicentre study, the risk of ectopic 
gestation among women who have undergone common methods of tubal 
sterilisation was found to be 7.3/1000 procedures. In the same study, it 
was found that the rate of ectopic pregnancy for all common methods of 
sterilisation combined in the 4th through 10th years after surgery was not 
lower than the rate of ectopic pregnancy in the first 3 years [74].  
 The risk of ectopic pregnancy depends on the method used for 
tubal sterilisation. All methods of tubal occlusion require correct 
application to maximize the effectiveness. The higher rate of failures are 
seen with spring clip application and bipolar coagulation  that highlight 
the requirement of proper techniques in the use of these methods as 
demonstrated by Hulka & Reich,Soderstrom et al.,[75,76]. The failure rate 
of pomeroy’s technique is estimated as  0.25-2.1[77] . 
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           The incidence of ectopic pregnancy is higher when tubal 
sterilisation is performed in the postpartum period because of the 
edematous, congested & friable fallopian tubes, which increases the 
chance of incomplete occlusion of the lumen [78].  
The probable explanation for the occurrence of ectopic gestation 
after tubal sterilisation is recanalisation or formation of tuboperitoneal 
fistula. Sperms can pass through these fistulas but the fertilized ovum 
cannot. So, implantation of fertilized ovum typically occurs in the distal 
segment of the tube [79]. Recanalisation results in abnormal reconstruction 
of the tubal lumen with formation of slit like spaces & blind pouches. 
This may results in ectopic implantation [78]. Fluid movements within the 
remaining segments may also influence the implantation [78]. The risk of 
ectopic gestation may be higher after electro coagulation procedures, than 
any other methods. To avoid luteal pregnancy, sterilisation should be 
performed in the early follicular phase.  
The ectopic pregnancy must not be disregarded in a woman who 
has undergone tubal sterilisation, particularly if two or more years have 
elapsed since the surgery [80].  
Previous caesarean section and other pelvic surgery  
A recent Danish register based study found a moderately increased 
risk of ectopic gestation in women who have undergone emergency and 
elective caesarean sections [81]. 
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A meta analysis by O’neil et al showed 5% increased odds of 
ectopic pregnancy among the studies included, but the estimate did not 
reach the statistical significance [82]. 
A case controlled study by michalas et al found that all types of 
pelvic surgeries increase the risk of ectopic gestation from a 2 fold 
increase for appendicectomy to a 9 fold increase for ectopic                         
pregnancy [83]. 
Tubal recanalisation surgery  
In a large series study from various hospitals, the risk of ectopic 
pregnancy after sterilisation reversal was reported to be 0.3 to 3% of all 
pregnancies [84]. 
 Microsurgical techniques for reversal of sterilisation provide better 
results than conventional surgery[85]. The lower rate of ectopic pregnancy 
in microsurgical technique is associated with  
1. Proper alignment of lumen, 
2. Gentle handling of tissues and 
3. Proper excision of all pathological tissues under magnification . 
Prior pelvic inflammatory disease  
 PID is defined as the infection of endometrium, fallopian tubes and 
contiguous structures by the ascent of micro organisms from the lower 
genito urinary tract [86]. It is most commonly associated with sexually 
transmitted infections, especially Chlamydia trachomatis & neisseria 
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gonorrhoea. These organisms often initiate the inflammatory process and 
then replaced by other opportunistic bacteria including anaerobes, 
aerobes and mycoplasma species [87]. Sexually transmitted infections 
represent a growing problem worldwide [88]. This concern is not only due 
to increasing incidence but also due to improved diagnosis. More than 
half of these infections are seen in young sexually active women aged 
between 16-25 years.  
Prior infection is a risk factor for current infection. With the 
development of repeated PID, the risk of ectopic pregnancy and 
subfertility is increased. Approximately 70% of Chlamydial infections are 
asymptomatic. A small proportion may present with Vaginal discharge,  
dysuria, lower abdominal pain, arthritis or post coital bleeding.  
The significance of infectious diseases in ectopic pregnancy is well 
documented [89, 90, 91, 92]. There might be a causal link. Declining 
Chlamydial infection rates attributed to preventive strategies and fall in 
the ectopic pregnancy risk in Sweden [93]. 
Multiple sexual partners and the young age at first intercourse are 
associated with increased risk of ectopic pregnancy (Bouyer et al). 
Smoking  
Many studies have reported that smoking is a major risk factor for 
the occurrence of ectopic pregnancy (odds ratio 1.7 - 3.9) [94]. Studies in 
animals and humans reported the effect of smoke exposure on oviductal / 
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fallopian tube function [95, 96]. Inspite of these findings, the exact 
mechanism by which the cigarette  smoking  increases  the  ectopic  
pregnancy risk  remains unclear. 
 A recent study has reported that cotinine  (an active nicotine 
metabolite)  increases the prokineticin  receptor , PROKR1 expression in 
the fallopian tube,  which is a regulator of smooth muscle contractility 
and a gene important for intrauterine implantation [97]. Cigarette smoking 
attenuates tubal PROKR 1 expression resulting in altered tubal function 
and provides the explanation for the link between smoking & risk of 
ectopic pregnancy. 
 Bouyer et al demonstrated a dose-effect relationship between 
smoking & risk of ectopic gestation [98]. Cessation of smoking reduces the 
ectopic pregnancy risk a level intermediate between that of current 
smokers & non - smokers. However, there was no trend observed for time 
since smoking cessation .  
Obesity and infertility  
 Obesity is a growing problem throughout the world and upto 25% 
of women in the reproductive age group are being obese (Balen and 
Anderson, 2007, Haslam and James, 2005). Obesity was found to be 
associated with reduced fecundity (Ramlau - Hansen et al 2007; vanden 
steeg et al, 2007). The obese women are more prone to anovulation and 
polycystic ovarian syndrome . (pasquali et al, 2007). In comparison to 
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normal weight women of reproductive age, obese women seek medical 
attention for their subfertility more often. (vahratian and Smith 2009). 
There are studies reported on the relationship between BMI and ectopic 
pregnancy.  
1. Zhang et al, 2010 
2. Sneed et al 2008 
3. Mataliotakis et al, 2008  
4. Fedorcsak et al, 2008  
5. Wittemer et al, 2000. 
None of the above mentioned studies found a significant difference 
between overweight and normal women. Bouyer et al ., 2003; Tanveer 
Shafquat et al., 2013 found that the ectopic pregnancy risk increased with 
the duration of  subfertility [98, 99]. However, ectopic pregnancy is a risk 
factor for subsequent infertility [100, 101, 102]. The association between 
infertility and ectopic pregnancy seems to be mutual risk factors and are 
likely to be complex.   
Ovulation induction and ART  
 The ovulation induction and other ARTs may be associated with 
increased risk of ectopic pregnancies [103]. There are many case reports of 
ectopic pregnancies following ovulation induction [104, 105].  
ART is a known risk factor for ectopic pregnancy. The rate of 
ectopic gestation is higher in pregnancies resulting from ART than in 
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spontaneous conception with the incidence ranging from 2% to 8.6% 
particularly in gamete & Zygote fallopian transfer (GIFT and ZIFT)[106, 
107]. Heterotopic pregnancies and bilateral tubal ectopic pregnancies, the 
rarest form of ectopic pregnancies have also been reported following IVF 
and embryo transfer (IVF - ET) and GIFT. 
The presence of tubal pathology and PID could be the predisposing 
factors as with tubal pregnancies (Cohen et al 1999). Deep deposition of 
the embryos in to the uterine cavity [108] or the usage of large volume of 
culture fluid during the embryo transfer [109] may result in ectopic 
pregnancies. Ectopic pregnancies are significantly lower when single 
frozen thawed blastocysts are transferred compared with two blastocysts. 
(Yanaihara et al, 2008; Ishihara et al, 2010). 
Previous ectopic pregnancies  
 A prior history of ectopic pregnancy is a possible indicator of the 
pre existing tubal damage and hence a strong risk factor for recurrence 
[73]. This is because tubal pathology is always bilateral and there is a 
strong tendency for ectopic gestation to occur first on one side and then 
on the other side later [110]. The patients with recurrent ectopic 
pregnancies are more likely to experience a tubal rupture [111]. A study 
reported that women with history of an ectopic pregnancy had 13 times 
higher the chance for the second ectopic compared to women who had a 
first live birth [112]. 
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Intrauterine contraceptive device use  
 Although IUCD users are supposed to be protected from both 
intrauterine and extra uterine pregnancy, it was found that a woman who 
conceives with IUCD in place is seven times more likely to have an 
ectopic pregnancy in comparison to a woman who conceives without 
IUCD [113]. Ectopic pregnancy is known to occur frequently in women 
who use certain types of IUCDs [114]. IUCD usage was found to increase 
the risk of ectopic pregnancy in a study conducted by Shaista [115] in 
Saudia Arabia and Bouyer et al [98] in France. Bouyer et al confirmed that 
previous intra uterine device use has increased risk of ectopic pregnancy 
per se not only through an association with pelvic infections  as 
previously suggested [116, 117].  
Progesterone contraceptive pills 
         Levonorgestrel - only emergency contraception is a well established 
emergency contraception. (Gemzell - Denielsson 2010). The risk of 
ectopic pregnancy should be kept in mind following LNG only 
emergency contraception failure. There are many cases of ectopic 
pregnancies reported in literature after the LNG only emergency 
contraception failure (Ghosh et al., 2009; Kozinszky et al., 2011). The 
rate of ectopic pregnancies following LNG only emergency contraception 
failure was 4.1% which was found to be higher than the incidence of 
1.1% to 1.6% in spontaneous pregnancies (Varma & Gupta 2009).  
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 In general estrogen stimulates the tubal myo - electrical activity 
and progesterone inhibits that [118]. Progesterone alters the tubal motility. 
Inversion of tubal peristalsis and reduced fimbrial beating may contribute 
to the delayed arrival of egg in the endometrial cavity, a fact resulting in 
ectopic pregnancy [119, 120, 121, 122]. Pharmacologic level of progesterone 
relaxes the tubal myo-electrical activity to an extent that the transport 
through the isthmus does not occur [123, 124]. Higher rates of failure are 
seen when emergency contraception is performed during the period close 
to ovulation [125].  
Prior history of abortions  
 Parazzini et al ., found that the rate of ectopic pregnancy was 
higher in women with history of prior induced abortions and also the risk 
increased with  the number  of  induced abortions in comparison to 
women with history of no induced abortions [126]. Spontaneous abortions 
might have a causal effect, most probably mediated by pelvic infection 
[127]. Bouyer et al found an association between induced abortions and the 
risk ectopic pregnancy, with an odds ratio of 1.9 for women with history 
of two or more previous induced abortions [98].  
Sites of ectopic pregnancy  
 Nearly all ectopic pregnancies are implanted in the fallopian tubes 
(97%) and a common factor for the occurrence of such ectopics are the 
presence of  a tubal pathology. 70% of ectopic pregnancies occur within 
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the ampulla.  The rate of ectopic pregnancy in different parts of the tube 
also varies [128] as mentioned below.  
Ampullary  - 70%  
Fimbrial - 11%  
Isthmic  - 12% 
          Interstitial   -         2.4% 
Fate of the tubal pregnancy  
1. Tubal mole 
The gestational sac with surrounding blood clot is retained within 
the fallopian tube. 
2. Tubal abortion  
This is more common if ectopic implantation occurs in the 
ampullary part of the tube. Separation of the sac and its expulsion into the 
peritoneal cavity via the tubal ostium occurs. 
Rarely reimplantation of the products of conception may result in 
secondary abdominal pregnancy. 
The bleeding usually stops if the expulsion is complete. Sometimes 
bleeding may persist in incomplete separation or bleeding from the site of 
implantation 
3. Tubal rupture  
This is more common in the isthmus, which is the narrower portion 
of the fallopian tube. Rupture may occur early in the anti mesenteric 
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border and results in massive intra peritoneal haemorrhage. If rupture 
occurs in the mesenteric border of the fallopian tube, a broad ligament 
haematoma can occur.  
Ectopic implantation can also occur outside the fallopian tubes, 
within the ovary, cervix, caesarean scars, uterine cornua and abdomen. 
These extra tubal implantations may not be associated with pre existing 
risk factor or tubal pathology. 
Cervical pregnancy  
Cervical pregnancy accounts for less than 1% and the rarest of 
ectopic pregnancies implanted in the cervical canal below the internal 
os[128, 129] . Induced abortions, prior uterine curettage, leimyomata, 
Asherman’s syndrome, IUCD, IVF are the predisposing factors. Raskin 
suggested that the ultrasound diagnosis of cervical pregnancy required the 
following 4 criteria [130]. 
1. Diffuse enlargement of the cervix  
2.  Enlargement of the uterus 
2. Amorphous intra uterine echoes. 
3. The absence of an intra uterine gestation. 
Timor - Tristch et al., refined the criteria and included that the 
placenta and the chorionic sac containing pregnancy must lie below the 
linternal os and the cervical canal must be enlarged like a barrel [131]. 
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Anticipation of significant bleeding and a plan to prevent / control 
haemorrhage can avoid hysterectomy. 
Ovarian Pregnancy 
 The incidence is 1 - 3%. The presenting signs & symptoms are like 
other ectopic pregnancies. It is difficult to make the pre operative 
diagnosis of an ovarian pregnancy. USG shows a walled cystic mass 
within or adjacent to the ovary. The differential diagnosis includes a 
corpus luteal cyst and a tubal implantation. The diagnosis is usually a 
pathological diagnosis made by histopathologic examination of removed 
adnexal mass based on the following speigelberg’s criteria [132].  
1. The  fallopian tube  should  be  normal  and  distinct  from the 
ovary.  
2. The gestational sac should occupy the normal anatomical position 
of the ovary. 
3. There should be a connection between the gestational sac and the 
uterus by utero - ovarian ligament. 
4. The definite ovarian tissue should be demonstrable in the wall of 
the gestational sac.  
Doppler USG cannot always distinguish the corpus luteal cyst from 
the ovarian pregnancy. Speigelberg’s criteria cannot be established with 
ultrasound[133].  
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Caesarean scar ectopic pregnancy  
 Although previously rare, the incidence of caesarean scar 
pregnancy is increasing worldwide [134]. This increase is presumably due 
to more number of caesarean sections and increased recognition. 
Caesarean scar ectopic pregnancy is surrounded by myometrium and the 
fibrous scar tissue completely and separated from the endometrial cavity 
and fallopian tube. Early diagnosis with ultrasound can avoid life 
threatening haemorrhage and uterine rupture.  
Cornual ectopic pregnancy  
 It is one of the most dangerous types of ectopic pregnancies with 
high maternal mortality. The incidence is 2 - 4% of all tubal pregnancies 
[135]. This type of pregnancy can be discovered with advanced gestational 
age due to the adjacent supporting myometrial walls and good vascular 
supply, particularly from the uterine artery [136, 137]. In case of rupture the 
bleeding can be fatal. Previous pelvic surgeries, uterine anomalies, ART, 
previous ipsilateral salphingectomy [138] are the risk factors.  
Isthmic tubal ectopic pregnancy  
 Upto 12%  of  ectopics are implanted within the isthmic portion of 
the fallopian tube [128]. The isthmic portion of the tube is narrow with a 
well defined muscularis layer. So, Isthmic ectopic pregnancies quickly 
invade the muscularis layer and rupture early [139].  
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Abdominal pregnancy  
 It is an extremely rare and dangerous form of extra uterine 
pregnancy [140]. Incidence is less than 1%. Many are due to secondary 
nidation within the peritoneal cavity after tubal rupture, tubal abortion or 
uterine rupture [141]. Primary abdominal pregnancy should satisfy the 
following criteria of Studdiford[142].  
1. Tubes and ovaries should be normal. 
2. There   should not be any uteroplacental fistula.  
3. The attachment to peritoneal surface early enough to exclude the 
possibility of secondary implantation. The placenta may be 
attached to bowel, mesentry, uterine wall, liver, spleen, bladder and 
ligaments. The placenta may separate at any time during pregnancy 
resulting in life threatening haemorrhage [143]. The maternal 
mortality rate can reach as high as 20% [144]. 
Bilateral tubal pregnancies 
They are extremely unusual occurrence in the absence of preceding 
ovulation induction. More common are twin pregnancies in the same tube 
and heterotopic pregnancies [145]. Fishback described the criteria for 
diagnosing bilateral tubal pregnancies. He claimed that there should be 
description of the fetuses or fetal parts as well as of placental tissue [146]. 
Norris declared that microscopic identification of chorionic villi in each 
tube should suffice [147]. 
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Clinical presentations of ectopic pregnancy 
Clinical manifestations of ectopic pregnancy usually appear six to 
eight weeks after the last menstrual period, but it can occur later 
depending upon the site of ectopic implantation [148]. The classic triad of 
ectopic pregnancy are  
1) Abdominal pain, 
2) Amenorrhoea and 
3) Vaginal bleeding. 
These symptoms can occur in both unruptured and ruptured cases. 
But unfortunately the classic triad is present only in 50% of patients [149]. 
Abdominal pain is the cardinal feature of ectopic pregnancy 
present in close to 100% of cases [150]. To start with dull pain caused by 
tubal stretching, sharp colicky pain follows.  
About 75% of the patients present with amenorrhoea of less than 6 
weeks. There is no history of amenorrhoea if rupture occurs in early 
weeks and if vaginal bleeding and pain starts around the next expected 
period. Amenorrhoea lasts even upto 16 weeks in case of cornual and 
interstitial pregnancies [151]. 
Abnormal vaginal bleeding or brownish vaginal discharge occurs 
in 50% of the patients [149].  Early vaginal bleeding simulating uterine 
abortion is seen in caesarean scar pregnancy [151].  
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These symptoms overlap with the symptoms of spontaneous 
abortion. A prospective study found no statistically significant difference 
in the presenting features of patients with early intrauterine pregnancies 
versus those with unruptured ectopic pregnancies [152].  
The patients may present with others common symptoms of early 
pregnancy including fatigue, nausea, breast fullness, heavy cramping and 
recent dyspareunia. Advanced abdominal pregnancy may present with 
painful fetal movements. 
 Late presentations after the rupture of the ectopic pregnancies are 
common in developing countries. They may present with dizziness, 
gastro intestinal symptoms like diarrrhoea, shoulder tip pain (due to 
massive haemoperitoneum), syncopal attacks and sudden cardiac arrest.  
 Some cases of intra peritoneal bleeding with pelvic haematocele 
could present with ‘toilet signs’, which include dysuria, urinary frequency 
and tenesmus. There are reported cases of patients with ectopic 
pregnancy fainting in the toilet or following sexual intercourse. 
Differential diagnosis of ectopic pregnancy  
 The following conditions mimic the ectopic pregnancy in their 
clinical presentation [153]. 
1) Pelvic inflammatory disease  
2) Dysmenorrhoea 
3) Endometriosis  
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4) Ruptured corpus luteal cyst  
5) Acute appendicitis  
6) Typhoid perforation  
7) Acute intestinal obstruction  
8) Acute diverticulitis  
9) Gastroenteritis.  
Physical examination  
 The physical examination findings of cases with ectopic 
pregnancies are highly variable and mostly unhelpful. Many patients 
present with stable haemodynamic status and benign examination 
findings, especially in unruptured ectopic pregnancy.  
Careful  assessment of vitals may show classical picture  of 
haemorrhagic shock including tachycardia, pallor, hypotension and 
oliguria [149] in case of ruptured ectopic pregnancy. 
 Other signs include presence of abdominal tenderness/guarding/ 
rigidity, abdominal distension, forniceal tenderness, positive cervical 
excitation test, forniceal bogginess or presence of any adnexal mass 
[149,154].  
 Tachycardia may not present in all cases of ruptured ectopic [154, 
155]. Abdominal tenderness/distension is not specific for ruptured ectopic 
pregnancy and it is present in almost all cases of surgical emergencies. 
 
34 
 
 Forniceal tenderness and cervical motion tenderness may present in 
PID and endometriosis other than ectopic pregnancy. So this sign is also 
not specific. An adnexal mass may be palpated, but it is difficult to 
differentiate the mass from the ipsilateral ovary. The patient’s discomfort 
may preclude the adequate pelvic examination and overzealous 
assessment may result in iatrogenic tubal rupture.  
 In a study conducted in Mumbai abdominal tenderness was present 
in 59.69%, abdominal distension in 31.12%,  forniceal tenderness in 
71.43%  and tender cervical movements in 69.89% and forniceal 
bogginess in 54%. Tachycardia and hypotension was seen in 52.55%. 
13.7% patients had no abdominal signs [154] .  
Cervical motion tenderness / cervical excitation test  
 Cervical motion tenderness is defined as an unpleasant sensation or 
response elicited on bimanual pelvic examination with movements of the 
cervix by the examiner’s  gloved  hand, usually indicative of 
inflammatory process  in the pelvic / adjacent organs that might be moved 
during such examination. (Stedman’s part of Lippincott Williams 
&Wilkins). 
         Cervical excitation test is a controversial sign. The examiner put a 
finger each side of the cervix and push it from side to side which in turn 
stretches the tubes. The examiner has to look the patient’s face for pain. 
Pushing the cervix forward or back may give false positive result. 
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Cervical excitation test may be positive in ectopic pregnancy and PID. 
Role of this test in ectopic pregnancy is controversial   because it might 
burst the unruptured ectopic pregnancy. So, this test should be done 
gently.  
Culdocentesis  
 Culdocentesis is an invasive procedure in which peritoneal fluid is 
aspirated from the cul de sac of a female patient. Spinal needle is 
introduced into the pouch of douglas through the vaginal wall.  
 Ultrasonography with its improved resolution and more availability 
has virtually replaced the culdocentesis as a procedure of choice. USG is 
an non invasive procedure and has sensitivity and specificity superior to 
that of culdocentesis in the diagnosis of  haemoperitoneum.  
Indications  
1) To diagnose suspected ruptured ectopic pregnancy in the 
following situations [156, 157, 158, 159].  
a) Haemodynamically unstable patients.  
b) When ultrasonography is not immediately available. 
2) In place of diagnostic peritoneal lavage to diagnose 
haemoperitoneum following blunt trauma abdomen.  
3) To diagnose ruptured ovarian cyst.  
4) To obtain fluid for culture in the treatment of PID.  
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Contra indications  
 Pelvic mass including tubo ovarian abscess, ovarian tumors, 
pelvic kidney and appendiceal abscess.  
 Fixed retroverted uterus.  
 Coagulopathy.  
 Prepubescence.  
 Non co-operative patient.  
Culdocentesis is considered positive when more than 2 ml of non 
clotting blood is obtained. Approximately 80-95% of ruptured ectopic 
pregnancies display non clotting blood on culdocentesis [157].  
A study by Romero et al reported that when both a positive 
pregnancy test and a positive culdocentesis were present, ectopic 
pregnancy was found in 99% of cases [160].  
About 15% of ectopic pregnancies show negative or non-diagnosis 
results on culdocentesis [159]. The false positive results are seen in 2.9% of 
cases. A ruptured corpus luteum in the presence of an intrauterine 
pregnancy is the common cause of false positive result [161].  
Complications are rare. However the following complications may occur. 
1) Rupture of an unsuspected tubo-ovarian abscess, ovarian teratoma, 
endometrioma or a malignant ovarian cyst.  
2) Puncture of the bowel or pelvic kidney.  
3) Rupture of tubal pregnancy. 
4) Bleeding from the puncture site. 
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In the emergency situations culdocentesis can be a safe, simple and 
critical diagnostic procedure. In an unstable woman with a strong 
suspicion of a ruptured ectopic gestation, culdocentesis may facilitate the 
live saving surgery by conforming the diagnosis without waiting for the 
time consuming ultrasound exams. Many recent studies from developing 
countries have shown that this simple procedure helped in the diagnosis 
of tubal ectopic pregnancy in more than 70-80% of cases [66, 162].  
Urine Pregnancy test  
The currently used urine pregnancy tests detect the monoclonal 
antibodies to the beta subunit of hCG. So, the possibility of cross-reaction 
with LH and TSH is reduced. However, the antibody reacts with both 
intact hCG, which is the major component in serum and also with the 
fragments of beta - subunit (beta core) which are the major form in urine. 
Small amount of  hCG are detected in the blood and urine of non 
pregnant patients [163] .  
hCG is secreted from the implanting blastocyst and first appears in 
the blood around  6-8 days after fertilization, the levels rise progressively 
and reach a peak around  7 – 10 weeks. Most urine pregnancy test kits 
have sensitivity to detect as low as 25 mIU/ml of hCG in urine. Urine 
pregnancy test may become positive 3-4 days after the implantation; by 7 
days (at the time of expected period), 98% will be positive [163]. A 
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negative result one week after the next expected  menstrual period 
virtually says that the woman is not pregnant [163, 164]. 
 A Urine pregnancy test for all reproductive age women 
experiencing vaginal bleeding or pelvic pain has been recommended                  
[165, 166].  
 A systemic review conducted in 1998 reported that UPT was 
accurate  (97 .41%) when used by health care professionals. The accuracy 
fell to 75% when used by consumers due to failure to follow instructions 
[167]. 
 A negative urine pregnancy test does not exclude ectopic 
pregnancy, because the placental implantation in tubal location can be 
either nonviable or compromised and therefore not able to secrete enough 
hCG for a positive pregnancy test. (Richard M. Soderstrom M.D). 
Around 5th to 7th week of pregnancy, urine concentration of the hCG beta 
core fragment, an hCG variant rise dramatically, interfering with hCG 
detection and can cause false negative test results [168]. 
Serum β-hCG concentrations  
 The most sensitive, gold standard test to diagnose the pregnancy is 
the quantitative serum β-hCG estimation. The hCG secretion begins no 
later than the blastocyst stage. The beta hCG levels vary according to the 
period of gestation. In a non pregnant woman beta HCG level is less than 
10mIU/ml. The estimated serum β-hCG 14 days after ovulation in a 
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singleton healthy pregnancy is about 100mIU/ml. The serum beta hCG 
level should double every 48-72 hrs in a healthy intrauterine pregnancy. 
The β-hCG levels are higher in multiple pregnancies [169]. A recent study 
reported that the minimum rate of rise in β hCG for a viable intra uterine 
pregnancy is 24% at first 24 hrs and 53% at 48hrs [170]. 
 Failure of β-HCG values to double as expected, suggests that the 
pregnancy is unhealthy [169]. Possibilities include an ectopic pregnancy or 
a non-viable intrauterine pregnancy which will miscarry.  
 A rapid decline in serum concentrations of β-hCG usually by 21-
35% or more over 2 days, is suggestive of spontaneous abortion [171] or a 
resolving ectopic gestation.  The concentration of serum β-hCG has no 
definitive pattern in ectopic pregnancy [172]. However, in more than 70% 
cases the serial β-hCG values decrease more slowly than that of 
miscarriage and increase more slowly than that of a healthy intra uterine 
pregnancy [173]. An ectopic pregnancy is more likely when an intrauterine 
gestational sac is not seen by transabdominal scan when β-hCG 
concentration is above 6500 IU/L or by transvaginal scan at a β-hCG 
concentration of more than 1500 IU/L [174]. Combined transvaginal 
ultrasound and serial serum β-hCG estimation are approximately 96% 
sensitive and 97% specific for diagnosing an ectopic pregnancy [169]. 
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Role of ultrasound in diagnosing ectopic pregnancy  
 Transvaginal sonography has revolutionized the approach to the 
diagnosis of ectopic pregnancy. TVS can confirm the diagnosis of an 
intrauterine pregnancy earlier than transabdominal ultrasonography 
(TAS). It has been reported that using transabdominal scan, an intra 
uterine gestational sac can be visualised when the serum β-hCG is >6500 
IU/L [175]. However using TVS an intrauterine gestational sac can be 
visualized when the serum β-hCG is as low as 1000 IU/L [176]. 
Transvaginal sonography is able to identify the gestational sac at 
gestational age of 5.5 weeks with almost 100% accuracy [177, 178]. Intra 
uterine pregnancy is diagnosed definitely by sonographic visualisation of 
a yolk sac or an embryo in addition to the gestational sac [179, 180, 181]. An 
ectopic pregnancy may show ‘Pseudosac’, a fluid collection within the 
cavity of endometrium that may result from the breakdown of the 
decidualised endometrium. Pseudosac is centrally located inside the 
endometrial cavity compared to early gestational sac that is eccentrical 
[182]. Pseudosacs wont have a good hyper echoic decidual reaction around 
them and they are transient. In addition, the yolk sac and cardiac activity 
must be visualised clearly after 6 weeks of gestational age. So, it is 
important to differentiate the pseudosac from an empty intra uterine sac 
in early pregnancy. 
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 The identification of an intrauterine gestation rules out the ectopic 
pregnancy unless a heterotopic pregnancy is strongly suspected [183]. The 
diagnosis of an ectopic pregnancy using the TVS is based on the positive 
visualisation of an extra uterine pregnancy [184]. It is classified as PUL if 
neither an intrauterine nor an extra uterine gestational sac is visualised on 
TVS. PUL should be followed until the final pregnancy outcome is 
known. 
Tubal ectopic pregnancy  
 It is the most common form of ectopic pregnancy. The ectopic 
mass is seen in the adnexa separately from the ovary [184].  There may be 
1) An extra uterine empty gestational sac with a hyper echoic ring 
sign.  
2) Inhomogeneous adnexal mass.  
3) An extra uterine gestational sac with yolk sac or/ and a fetal pole 
with or without cardiac activity [181 ,185].  
It has been reported that an inhomogeneous adnexal mass may be 
seen in an early ectopic pregnancy or a resolving ectopic pregnancy [186].  
Interstitial ectopic pregnancy  
An interstitial or cornual ectopic pregnancy can be diagnosed with 
the following criteria. 
1) Absence of gestational sac inside the endometrial cavity.  
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2) Products of conception are seen outside the endometrial cavity 
and with a continuous rim of myometrium surrounding it [187].  
Cervical ectopic pregnancy  
A cervical pregnancy is diagnosed by  
1) Absent intrauterine gestational sac.  
2)  Enlarged and Barrel – shaped cervix. 
3) The gestational sac which lie below the internal cervical os. 
4)  Absent ‘Sliding sign’ (when probe pressure is applied to cervix, 
the gestational sac slides against the endocervical canal in a 
miscarriage but this sign is absent in cervical pregnancy). 
5) Blood flow surrounding the gestational sac in doppler ultrasound 
[188, 181]. 
Ovarian pregnancy  
 No specific criteria available for the sonological diagnosis of an 
ovarian ectopic pregnancy. 
Caesarean scar ectopic pregnancy  
The diagnosis is made by  
1) Absent intra uterine gestational sac. 
2) The gestational sac is located at the level of the internal os 
anteriorly  and covers the previous caesarean section scar. 
3) Blood flow on doppler ultrasound. 
4) ‘Sliding sign’ will be absent [189].  
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The heterotopic pregnancy  
In heterotopic pregnancy, an intra uterine pregnancy is present in 
conjunction with an ectopic pregnancy.  
Many studies have shown that TVS has high diagnostic accuracy 
for ectopic pregnancy with 87 – 99% sensitivity and  94.99% specificity 
[190, 191, 192, 193] .  
False positives can occur if other structures like corpus luteum, 
bowel, a hydrosalphinx, a para tubal cyst or an endometrioma are 
mistakenly taken as an ectopic pregnancy. If the ectopic is small or 
concealed by uterine anomalies or fibroids or by bowel, it can be missed. 
Around 80% of the ectopic pregnancies are seen on the same side 
as that of the corpus luteal cyst. We have to search for any adnexal mass 
in the presence of corpus luteum . Visualisation of free fluid in the pouch 
of douglas increases the suspicion of an ectopic pregnancy [194]. However 
a minimal collection due to increased vascular permeability in early 
pregnancy is common. 
Role of CT and MRI in ectopic pregnancy 
Because of its lack of ionizing radiation and better soft tissue 
contrast, Magnetic Resonance Imaging is being frequently used in 
pregnant patients.  
         Sonography is the investigation of choice in diagnosing the early 
intra uterine pregnancy and ectopic pregnancy. Sometimes sonography 
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may fail to detect even an advanced ectopic pregnancy because of its 
inherent limited resolution, especially in patients with severe pain with 
non ideal body habitus. MRI can sometimes serve as a problem solving 
too l [195-196]. 
MRI should be reserved for haemodynamically stable patients in 
whom additional information is necessary for further management and 
that cannot be obtained using sonography [197,198]. 
MRI offers the following benefits as compared with sonography 
1. Mutiplanar imaging, 
2. Greater soft tissue contrast, 
3. Lack of ionizing radiation and 
4. More specific characterisation of tissues and fluids [199]. 
CT is frequently performed imaging modality in the evaluation of 
pelvic and abdominal pain of unknown cause. CT is certainly not a 
preferred modality to diagnose an ectopic pregnancy, particularly for a 
condition that can be imaged using other modalities. CT findings of 
ectopic pregnancy are not well recognized because CT is generally contra 
indicated in pregnant women due to its ionizing radiation.  
Many classic sonographic features of an ectopic pregnancy have 
their CT and MRI correlates. So, the familiarity of various sonographic 
signs of ectopic pregnancy and their correlation with CT and MRI 
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findings facilitates prompt and accurate diagnosis and further 
management.  
A recent study by Takahashi A et al proved that MRI is an 
effective modality for diagnosing the ectopic pregnancy with 91.3% 
sensitivity, 100% specificity and 100% positive predictive value [200]. 
Serum Progesterone level 
The estimation of serum progesterone level is useful in the 
assessment of PULs [201]. The level is more than 50ng/ml in a healthy 
intra uterine pregnancy. However, the measurement of serum 
progesterone levels could not differentiate an ectopic pregnancy from a 
case of early IUP or a miscarriage [202]. In case of pregnancy of unknown 
locations, progesterone level of <5ng/ml is used to differentiate the low 
risk patients who can be managed conservatively and the at risk patients 
who require definitive management [203] . 
Other serum biomarkers 
Although many other serum biomarkers like 17α hydroxy 
progesterone, Inhibin - A, IGFBP - 1 have been reported , none of these 
biomarkers are used in day to day practice [204] . A recent study by 
Andrew Horne et al showed that the placental growth factor is a key 
factor in neovascularisation and it is a promising   biomarker for ectopic 
pregnancies [201]. 
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Diagnostic laparoscopy 
  When ultrasound is inconclusive but an ectopic pregnancy is 
suspected, a diagnostic laparoscopy may be done. Diagnostic laparoscopy 
is the gold standard investigation in the ectopic pregnancy. Delay in the 
diagnostic laparoscopy has been highlighted as one of the reason for 
maternal mortality [205]. However, sometimes small ectopic pregnancies 
may be missed during laporoscopy or laparotomy [201]. An alternative to 
diagnostic laparoscopy is serial USG examinations with β-hCG 
measurements or an endometrial biopsy or an empirical medical therapy. 
Role of endometrial biopsy in ectopic pregnancy 
 In selected cases of pregnancy of unknown locations, an 
endometrial sampling can be done and analysed for the presence or 
absence of chorionic villi. It is useful when performed after a negative 
diagnostic laparoscopy for a suspected case of an ectopic pregnancy 
(Vanitha N Sivalingam et al) [94] . 
MANAGEMENT OF THE ECTOPIC PREGNANCY 
An ectopic pregnancy can be managed by any of the following method 
1) Expectant management. 
2) Medical management. 
3) Surgical management. 
4) Surgically administered medical management. 
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Expectant management 
Sometimes, without any intervention ectopic pregnancies may 
regress to abortion with only minimal bleeding or they may be 
reabsorbed. The greater challenge lies in the identification of these cases 
in which intervention is not necessary. 
Expectant management was first described by Lund (1955) in 
women with ectopic pregnancies [206]. He compared the expectant 
management versus the open surgery in a retrospective study. 
Surprisingly, the expectant management was successful in 57% of 
women. 
Inclusion Criteria (Elito et al, 2008)[207] 
1) Patients with stable haemodynamic status. 
2) Falling beta-hCG levels of more than 15% in a time interval of 24 
to 48 hrs. 
3) Initial level of serum beta-hCG less than 1,500 mIU/ml. 
4) The size of the adnexal mass should be less than 3.5 cm and it 
should be extra ovarian .  
5) There should not be any demonstrable embryonic cardiac activity. 
6) The patients who want to retain their future fertility. 
7) The patients willing to sign the consent form. 
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Follow-up 
Weekly serum Beta-hCG levels should be done until the level 
becomes undetectable.  Usually it will take around 3 weeks  for the 
complete resolution of an ectopic pregnancy ( 4 to 67 days).  
Routine transvaginal scan is not necessary during the course of 
falling beta-hCG . Transvaginal scan and  haematocrit should be done in 
all patients with the complaint of severe and prolonged abdominal pain to 
rule out the rupture .  Small amount of fluid collection in POD is a 
common finding in most of the patients. The amount of free fluid 
increases with the tubal abortion. But, the surgical intervention is 
recommended only in haemodynamically unstable patients and in patients 
with tubal rupture .The complete disappearance of the adnexal mass in 
scan may take as long as 3 months. During this time period , we should 
advise  the patients to avoid  pregnancy. Hysterosalpingography should 
be done after the disappearance of tubal mass in ultrasound. 
Predictive factors of success [208,209]. 
1) Declining level of beta-hCG over first 24 to 48hrs interval. 
2) The level of initial serum beta hCG should be low. 
3) No identifiable gestational sac like structure during ultrasound 
examination . 
4) Longer the period of amenorrhoea. 
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Reproductive future 
The fertility of women after the expectant  management of  an  
ectopic pregnancy could  be determined by hysterosalpingogram  or a 
spontaneous conception following the treatment [210,211]. 
Hysterosalphingography is a good method to evaluate the patency 
of the tubes [212] .  HSG is considered as  an important diagnostic 
procedure after  the conservative management of an ectopic gestation  
(Mol et al., 1997)[213] Routine hysterosalpingography is usually advised  3 
months after the completion of  expectant management . 
Elito et al. (2005a) reported the tubal patency rate of around 78%  
in   expectantly managed women , and it was similar to the results of 
other studies conducted by Stovall and debby [214,215,211] . 
Medical treatment 
Systemic treatment 
Methotrexate has been used for treating the gestational 
trophoblastic disease since 1956[216]. MTX inhibits the dihydrofolate 
reductase enzyme which is important in the synthesis of active form of 
folate used in RNA and DNA precursor synthesis. Side effects are 
commonly seen with multiple doses of MTX. Side effects are usually 
minimal including gastritis, nausea, vomiting, giddiness and ulcerative 
stomatitis. But, severe complications like neutropenia, pneumonitis and 
reversible alopecia can occur rarely. Folinic acid, a MTX antagonist can 
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be used to reduce the side effects, especially when multiple doses of 
methotrexate are used [217]. 
The medical treatment of an ectopic pregnancy with multiple doses 
of intramuscular MTX started in 1982 by Tanaka et al., [218]. In 
1989,Stovall et al., conducted an important study and they individualised 
the dosage of methotrexate to improve the  patient compliance, to reduce 
the overall costs and to minimise  the side effects like pneumonitis, which 
ultimately led to single-dose MTX regimen of 50 mg/m2 body surface 
area intramuscular use without folinic acid [219]. 
Selection criteria 
Complete blood count, liver function tests, serum creatinine and 
blood grouping and Rh typing should be done in all patients before 
starting the treatment. Chest x-ray should be taken in patients with prior 
history of lung diseases. 
Inclusion Criteria for Systemic Methotrexate treatment ( ASRM 
Practice Committee, 2008;  Elito et al, 2008). 
1) Patients with stable haemodynamic status. 
2) The size of the adnexal mass should be less than 3.5 cm and it 
should be extra ovarian .  
3) The patients who want to retain their future fertility. 
4) The patients should sign the consent form. 
5) The patients should be willing for follow up. 
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6) There should not be any severe or persistent abdominal pain. 
Absolute Contraindications for Systemic Methotrexate treatment ( 
ASRM Practice Committee, 2008 ; Elito et al ,2008). 
1) The presence of an intrauterine pregnancy. 
2) Moderate to severe anaemia.  
3) Thrombocytopenia (Platelets < 100000). 
4) Leukocyte count less than 2000 Cells/ Cumm . 
5) Sensitivity to Methotrexate . 
6) Immuno compromised patients. 
7) Active lung disease. 
8) Active gastric ulcer. 
9) Lactating women. 
10) Renal and hepatic failure. 
Relative Contraindications for Systemic Methotrexate treatment                        
(ASRM Practice Committee, 2008; Elito et al, 2008) 
1) Detectable embryonic cardiac activity by ultrasound. 
2) Initial beta hCG concentration of more than 5,000 mIU/ml. 
3) Falling beta-hCG levels of more than 15% in a time interval of 24 
to 48 hrs. 
4) Patients not willing for blood transfusion. 
5) Patients not willing for follow-up. 
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Methotrexate protocols (single dose regime and multiple dose regime) 
Single dose methotrexate regime and multiple dose methotrexate 
regime are two commonly used medical management protocols 
(Barnhart, 2009) [26]. 
In single dose methotrexate treatment 50mg/m2 intramuscular dose 
of MTX is used without folinic acid [220,221].  Follow-up serum beta-hCG 
levels are done on days 1, 4 and 7 after MTX injection. Second dose of 
MTX (50mg/m2) should be given in patients with less than 15% fall in 
their initial beta hCG level between day 4 and day 7. Patients with more 
than 15% fall in their initial beta hCG level should be followed weekly 
until the level falls below 5 mIU/ ml. The term ‘‘single dose’’ actually 
describes the number of MTX  injections planned, but the treatment may 
include additional doses of MTX injections of maximum 3 doses when 
the response is  not adequate [220,26]. 
In multiple-dose protocol 4 intramuscular doses of MTX (1mg/kg) 
are given on alternate days with 4 intramuscular doses of  leucovorin (0.1 
mg/kg). Serum beta-hCG levels are done on the day of MTX injection. 
MTX injections are continued until the level of beta-hCG falls by 15% 
from its peak concentration. Approximately 50% of cases won’t require 
the full 8-day regimen course (Pisarka et al.,)[222]. 
A meta-analysis by Bankart et al., showed 93% success rate for 
multiple-dose treatment and 88% for single-dose treatment [223].One study 
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by Lipscomb et al., reported that medical management was successful in 
78%–96% of selected patients [224]. 
Follow-up 
Serum beta-hCG levels are monitored weekly until the level of 
beta-hCG becomes negative. It usually takes 2 to 3 weeks for the 
complete resolution of an ectopic pregnancy after MTX treatment  in 
majority of  the cases, but can take as long as 6 to 8 weeks which depends 
on the pre-treatment beta-hCG levels [221.223]. When falling beta-hCG 
levels rise once again, there is a possibility of persistent trophoblastic 
tissue. 
The tubal mass may take 3 to 6 months for its complete resolution 
in the ultra sound [225]. Therefore, serial ultrasound evaluation after MTX 
treatment cannot predict the treatment failure, unless the tubal rupture is 
observed [226]. 
The following instructions should be followed after medical 
management 
1) Patients are advised to avoid the sexual intercourse until beta-hCG 
level becomes negative, 
2) Avoid alcohol use, non steroidal anti inflammatory drugs, foods 
and multi vitamins containing folic acid, 
3) Avoid sun exposure to minimize the risk of dermatitis, 
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4) Patients should not get pregnant for at least 3 months because of 
the risk of teratogenicity. 
Life-threatening complications are rare. Many patients complain of 
pain between 3 to 7 days after the onset of treatment, but it usually 
resolves within 4 to 12 hours [227]. In acute onset of pain, tubal rupture 
should be ruled out .An emergency surgery should be performed if tubal 
rupture is suspected. 
Signs suggesting treatment failure or possible rupture include 
1) Increasing abdominal pain, regardless of the beta-hCG levels.  
2) Haemodynamic instability and  
3) Rapidly rising beta-hCG concentrations after methotrexate 
treatment. 
Some commonly encountered treatment effects of methotrexate are  
1) Increase in beta-hCG level during the initial few days of therapy, 
2) Increase in abdominal girth, 
3) Bleeding or spotting per vaginum and  
4) Abdominal pain between day 3 to day 7 after the onset of 
treatment. 
Predictive factors of success 
Initial beta-hCG level before the onset of treatment is the single 
most important factor in the prediction of treatment success. The invasion 
of the trophoblastic tissue in ectopic pregnancy can be predicted from the 
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serum beta-hCG levels. The higher the serum beta-hCG level, the greater 
is the invasion of the trophoblastic tissue and the lesser is the treatment 
success with MTX [63]. If the serum beta-hCG level is low, then the 
chance of treatment success is high. 
The increase in beta-hCG concentrations before the onset of 
treatment and following MTX treatment are the more accurate predictors 
of tubal rupture than the level of beta-hCG on the day of MTX therapy. 
Ultrasound imaging is another important consideration. Better 
results are observed with haematosalpinx and the worse results are 
observed with a live embryo.  
Other predictors of treatment success are 
1) Size of the gestational mass less than 3.5 cm, 
2) Endometrial thickness less than 7 mm, and 
3) Absence of intra peritoneal bleeding [221,228]. 
Therefore, predictors of   treatment failure include 
1) The presence of moderate or large amount of free fluid in the 
peritoneal cavity. 
2) Initial beta-hCG levels higher than 5000 mIU/ml, 
3) The pretreatment rise in the serum beta hCG level of more than 
50% over a 48 hours period, 
4) The presence of   cardiac activity in the embryo (ASRM Practice 
Committee, 2008). 
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Reproductive future 
The fertility outcome of conservatively treated patients with MTX 
for an unruptured  ectopic pregnancy can be evaluated by 
hysterosalpingography  or  by spontaneous conception [211,229] .The 
radiologically normal tubes after medical treatment are shown to be 
associated with less risk of ectopic gestation  in future pregnancy. 
However, the normal radiological findings show nothing about the tubal 
function, where tubal dysfunction can also be a cause of ectopic 
pregnancy.  
Lipscomb et al. (2000) reported that 65% of patients succeeded 
with subsequent intra uterine pregnancies after medical management. The 
incidence of recurrent ectopic pregnancy in the study population was 
around 13% [230].  
Surgically administered medical management 
In a surgically administered medical management methotrexate is 
administered locally into the gestational sac either transvaginally under 
the ultrasound guidance or under the laparoscopic guidance. Local 
treatment is aassociated with less adverse effects of systemic 
methotrexate . 
 Drugs that can be used for local treatment are 
1) Methotrexate 1mg/kg [231,232,233], 
2) KCl 
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3) Prostaglandins, and 
4) Hyperosmolar glucose. 
Feichtinger and Kemeter first demonstrated the local treatment of 
an ectopic pregnancy with MTX in 1987 .They injected 10 mg of MTX 
into the gestational sac of tubal ectopic pregnancy transvaginally under 
the ultrasound guidance.  That case was successfully treated without 
adverse effects [231]. 
Selection criteria 
Surgically administered medical management is preferred in 
ectopic pregnancies with embryonic cardiac activity, particularly in cases 
of extra tubal ectopic pregnancies [207]. Systemic MTX treatment is 
preferred in ectopic pregnancies without embryonic cardiac activity.  
Local injection of MTX is comparatively safe and equally effective as 
systemic methotrexate, this local approach requires an additional invasive 
procedure which needs expertise and additional cost. 
An important consideration is that the correct dose of MTX used 
for local treatment is yet to be determined [234,235,236]. Most commonly 
used dosage is 1mg/kg body weight.   
Compared to local treatment, systemic methotrexate can be used 
easily. Therefore, local administration of MTX is restricted to non-tubal 
ectopic pregnancies with embryonic cardiac activity [237]. 
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Follow-up 
Serum beta-hCG levels are done on day 4 and day 7 after the MTX 
injection. Any patient with less than 15% fall in beta-hCG levels between 
day 4 and day 7, should be given an additional 50 mg/m2 intramuscular 
dose of MTX.  Local treatment is less effective in patients with high 
initial levels of serum beta-hCG and an additional injection of systemic 
MTX will improve the results. Hysterosalphingography should be 
performed after 3 months.  
Surgical Treatment  
Until the last 2 decades, ectopic pregnancies were usually treated 
by total salpingectomy (removal of the entire tube) via laparotomy. 
Today, laparoscopic surgery is preferred for treatment of ectopic 
pregnancies. 
Laparotomy is reserved for 
1) Ruptured ectopic pregnancies with severe intra abdominal 
bleeding, or 
2) In the presence of extensive adhesions. 
If the ectopic gestation is diagnosed early, before the tubal rupture, 
a laparoscopic salpingostomy can be performed. In this technique, the 
fallopian tube is opened and the products of conception are removed 
while leaving the tube in place. The tube then heals on its own. 
59 
 
A partial salpingectomy, also known as segmental resection can be 
performed in small ectopic gestation with the healthy fimbrial ends. In 
case of partial salphingectomy the remaining segments of the tubes can 
be reunited later using micro surgery. 
If the tubes are extensively damaged, or if the ectopic pregnancy is 
large and bleeding profusely, a total salpingectomy should be performed.  
In some cases when the ectopic gestation involves the ovary, a 
portion of the ovary or the entire ovary needs to be removed along with 
the fallopian tubes. This is called salphingo oophorectomy. 
Surgical management should be done in all cases of ruptured 
ectopic pregnancy. 
The laparoscopic surgery is preferred to an open surgery in 
haemodynamically stable patients. Laparoscopic surgery has many 
advantages as mentioned below. 
1) Lower analgesia requirements, 
2) Shorter operative times, 
3) Less intra operative blood loss and  
4) Shorter duration of hospital stay [238,239,240]. 
Laparotomy should be reserved for ruptured ectopic pregnancies 
with haemodynamic instability.  
If the opposite tube is healthy, total or partial salpingectomy is 
preferred depending upon the condition of the tube. 
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Studies have reported that the subsequent rate of intra uterine 
pregnancy is not increased after salpingostomy compared to 
salpingectomy in patients with healthy contralateral tube. In addition, 
salphingostomy exposes the women to the risk of bleeding and persistent 
trophoblastic tissue [173]. According to current guidelines, the procedure of 
choice in the presence of a healthy contralateral tube is laparoscopic 
salpingectomy.[241] 
In the presence of diseased contralateral tube, a laparoscopic 
salpingostomy should be considered if the patient desires future fertility. 
Persistent trophoblast is the problem of concern after salpingostomy. 
Persistent trophoblast should be considered in the following situations.  
1) Where the size of the ectopic pregnancy is more than 2 cm, 
2) Presence of active tubal bleeding and  
3) If serum β-hCG concentrations are more than 3000 IU/L or rising 
prior to the surgery [242].    
Women with persistent trophoblast should be monitored with serial 
β-hCG estimation and sometimes systemic methotrexate therapy may be 
needed if there is inadequate fall [243]. 
Many clinicians prefer a salpingectomy because this procedure is 
easier to perform and less time consuming than a salpingostomy. 
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Management of an Interstitial ectopic pregnancy 
The surgical management ranges from exploratory laparotomy and 
cornual wedge resection to hysterectomy in case of uncontrolled 
bleeding. 
The ultrasound criteria for diagnosing an interstitial ectopic 
pregnancy are 
1) Absent intrauterine gestational sac. 
2) Eccentrically placed gestational sac, 
3) The presence of a separate chorionic sac at least 1 cm from the 
lateral edge of the uterine cavity, and 
4) The gestational sac with the surrounding myometrium with a 
thickness of atleast 5mm [244,245]. 
Haemodynamically stable patients with unruptured early interstitial 
pregnancies could be managed conservatively with intramuscular MTX 
injection or surgically administered medical treatment. 
Management of cervical ectopic pregnancy 
The classical treatment for a case of cervical ectopic pregnancy is 
hysterectomy. But, hysterectomy is the cause of significant morbidity and 
infertility. There is high chance of massive bleeding and urinary tract 
injuries.       
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The vaginal bleeding can be managed conservatively by 
1) Local haemostatic stitches, 
2) Curettage, 
3) Uterine artery embolization and  
4) Application of an intracervical balloon tamponade [246,247]. 
However, these conservative procedures are often ineffective and 
result in hysterectomy in majority of the patients. 
The early asymptomatic cases of cervical ectopic pregnancies can 
be managed medically using local or systemic methotrexate [248,249]. 
Factors associated with the failure of systemic MTX treatment in 
cervical ectopic pregnancy are 
1) The beta hCG levels more than 10,000 mIU/ml, 
2) More than 9 weeks of gestation, 
3) The presence of detectable embryonic cardiac activity and 
4) The crown-rump length of more than 10 mm [250]. 
A combination therapy with intra-amniotic methotrexate injection 
increases the success rate. 
Management of caesarean scar pregnancy 
Period of gestation determines the management. A caesarean scar 
pregnancy can be managed by any of the following methods. 
1) Expectant management, 
2) Medical treatment and  
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3) Surgical management.  
Laparotomy and hysterectomy is the management of choice for 
haemodynamically unstable patients presenting with shock. In 
haemodynamically stable patients the scar thickness should be assessed 
before the administration of medical management. Non-surgical 
procedure is appropriate when the trophoblast reaches the vesico-uterine 
space. Expectant management has high risk of subsequent rupture. In 
medical management, the methotrexate injection can be given locally, 
systemically or in combination. 
The risk of scar rupture and heavy bleeding are seen in medical 
management. So it should be combined with either 
1) Intracervical vasopressin injection in combination with 18 Foley 
catheter balloon tamponade or 
2) Bilateral uterine artery embolization [251]. 
Management of an Ovarian pregnancy 
When diagnosed early, ovarian pregnancies can be managed by 
laparoscopic surgeries.  Medical management with MTX can be used in 
carefully selected patients with ovarian pregnancy, but the selection 
criteria are not defined. The systemic MTX may also be used to treat the 
persistent trophoblastic tissue after laparoscopy [252]. 
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Management of abdominal pregnancy 
Treatment is easy in earlier stage of pregnancy. The following 
ultrasound criteria are suggested as diagnostic  
1) Absence of an intrauterine pregnancy.  
2) Absence of both tubal mass and a complex adnexal mass, 
3) A wide mobility similar to fluctuation of the sac, evident with 
pressure of the transvaginal probe towards the POD. 
4) A gestational cavity surrounded by bowel loops and separated by 
peritoneum, 
MRI is more reliable in the diagnosis of this condition. 
Before surgery be ensure that  
1) Multidisciplinary surgery team is ready, 
2) Pre-operative arterial embolization done,  
3) Blood and blood products are adequately available and 
4) Bowel is prepared.  
The traditional management was laparotomy and removal of the 
fetus with or without placenta [253]. Risk of torrential bleeding from the 
placental bed is an important consideration in removing the abdominal 
pregnancies after first trimester. Adjuvant methotrexate therapy along 
with the pre operative arterial embolization is suggested to control this 
bleeding [254].  
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Management of heterotopic pregnancy 
More than 50% of the heterotopic pregnancies present late after 
rupture. Surgery is usually required and MTX usage is contraindicated in 
heterotopic pregnancies [255,256]. In case of heterotopic pregnancies with a 
viable intrauterine pregnancy and a non-tubal pregnancy with embryonic 
cardiac activity, KCL can be injected locally under ultrasound guidance. 
But, the follow-up after medical management is difficult because serum 
beta-hCG cannot be used as a reliable marker and ultrasound is not a 
good method to follow up the patient. 
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MATERIALS AND METHODS 
Study area 
The study was conducted at Tirunelveli medical college hospital. 
TVMCH is a tertiary care centre and a teaching hospital for 
undergraduate and post graduate students. It is a main referral centre for 
all primary health centres and government hospitals, situated in 
Tirunelveli ,Tuticorin and Kanyakumari districts. 
Study design 
The study was a cross-sectional study. 
Sample size 
The study consists of ‘n’ no of ectopic pregnancy cases attended 
Tirunelveli Medical College Hospital  Obstetrics and Gynaecology 
department for a particular time period. 
Duration of the study 
From  July 2012 to June 2014 for a period of  2 years. 
Inclusion criteria 
All cases of ectopic pregnancy / suspected ectopic pregnancy by 
clinical or sonological method. 
Exclusion criteria 
The study involved all cases of ectopic pregnancy. There was no 
exclusion criteria. 
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Methods and materials 
Data collection tool was used to collect the different information. 
Face to face interviews were conducted using data collection tool by the 
investigator including detailed history taking and relevant physical 
examination. 
A detailed history was taken from the patient ( if  the patient was in 
shock the history was taken retrospectively). After taking history physical 
examination was done especially for vital signs, abdominal examination, 
per vaginal examination, cervical excitation test and  culdocentesis when 
needed. 
The basic investigations including haemoglobin, renal function 
test, blood grouping and Rh typing, urine pregnancy test and ultrasound 
examination were done in all patients. Additional investigations like 
serum beta hCG,  doppler study, CT, MRI were ordered in case of 
doubtful diagnosis. 
All data were collected on a structural data form (sample enclosed) 
and analysed for descriptive statistics. Information regarding patient 
profile , risk factors , sterilisation status , use of other contraceptive 
methods , presenting symptoms and signs , physical examination , 
ultrasound findings , types of treatment , per operative findings , no of 
transfusions , post operative morbidity  and length of hospital stay were 
analysed.  
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Post operatively HPE reports were collected from the pathology 
department and final diagnosis was made. 
Data were summarised in tables and figures. For calculation of 
sensitivity, specificity, positive and negative predictive values for the 
diagnosis of ectopic pregnancy, 2- by-2 contingency tables were used. 
Ethical clearance 
Ethical clearance was obtained from the TVMCH ethical 
committee. Permissions from the head of the departments of Obstetrics 
and Gynaecology, Radiology and Pathology were obtained in written 
form prior to the ethical clearance. All details of the patients remained 
confidential. All patients were treated according to the hospital protocol. 
RESULTS 
A total of 138 patients were recruited in the study. The study 
population  was  estimated  to be  0.94%  of  total deliveries (14,688)  and  
0.73% of  total gynaec ward admissions (18,939)  during the study 
period.  
5 patients in the study had undergone medical management. 
Remaining 133 patients had undergone laparotomy. During laparotomy 
124 patients were found to be having ectopic pregnancy which was 
confirmed by histopathology. One patient had heterotopic pregnancy. 
One patient had negative laparotomy. Remaining 7 patients had other 
gynaecological lesions. 
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18939 patients were admitted in the gynaec ward 
From  July 2012 to June 2014 
 
138 (100%) patients were recruited in the study 
suspected to have ectopic pregnancy 
 
5 (3.6%) patients had  
medical management 
133(96.4%)  patients   
had   laparotomy 
124(89.9%) 
ectopic 
1(0.7%) 
heterotopic 
1(0.7%) 
PUL 
7(5.1%) 
gynaec lesions 
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AGE OF THE STUDY PARTICIPANTS 
 
63.8% of the study population belongs to 21 to 30 years of age. 
49 (35.55%)  patients were more than 30 years of age. 
 
Among the study population 74.5% were multigravida and 24.6% 
were primigravida. 
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PERIOD OF AMENORRHOEA 
 
 
LMP was not known in 19(13.8%) patients .  
75 ( 54.3%) patients were presented with  >5 weeks to 8 weeks of 
amenorrhoea. 
29 (21.0%) patients were presented with >8 weeks to 11 weeks of 
amenorrhoea. 
2 (1.4%) patients had more than 11 weeks of amenorrhoea. 
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URINE PREGNANCY TEST 
 
 
 
Urine pregnancy test was positive in 122 patients (88.4%). 
Negative in 6 patients (4.3%). 
Weakly positive in 10 patients (7.2%). 
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DURATION OF SUBFERTILITY 
 
 
13% of  women had 1 to 5 yrs of subfertility. 
7.2% of women had 5 to 10 yrs of subfertility. 
1.4% of women had 10 to 15 yrs of subfertility. 
3.6% of primi gravida conceived immediately after marriage. 
9.4 % of primi gravida conceived within one year. 
65.2% of patients were parous women with atleast one live child. 
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STERILISATION STATUS 
 
 
Among the parous women with atleast one live child 25(18.1%) 
were sterilised  and  66 (47.8%) were not sterilised. 
NA- not applicable. 
47 (34.1%) patients are primi gravida and multi gravida with no 
live child. 
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TIME SINCE STERILISATION 
 
The duration  between the sterilisation and  the occurrence of 
ectopic pregnancy was 1-3 yrs in 7 (28%) patients, 4 to 10 yrs in 16(64%) 
patients , > 10 yrs in 2(8%) patients. 
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METHOD OF STERILISATION 
 
 
 
Among the sterilised women 11(44%) patients had concurrent 
sterilisation, 
4 (16%) patients had laparoscopic sterilisation, 6 (24%) patients 
had puerperal sterilisation  and 4(16%) patients had total abdominal 
tubectomy. 
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OTHER CONTRACEPTIVE USE 
 
 
99 patients did not use any contraceptive method .  
8 patients gave history of IUCD use, but only one patient 
conceived with IUCD in situ. 
1or 2 patients gave history of usage of condom , emergency pills , 
oral contraceptive pills .  
2 patients were conceived during lactational amenorrhoea. 
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RISK FACTORS 
s. no Risk factors No of patients 
1 Prior H/O abortions 25 
2 Prev LSCS 44 
3 Sterilisation 25 
4 Tubal recanalisation 1 
5 Other pelvic surgeries 1 
6 Prev ectopic 6 
7 PID 19 
8 Ovulation induction 7 
9 ART 3 
10 IUCD 8 
11 Emergency pills 1 
12 MTP pills 6 
13 Combined OCP 1 
14 POP 1 
15 No risk factors 37 
 
Previous LSCS was the most common risk factor followed by tubal 
surgeries, abortions and PID. In some cases more than one risk factor was 
seen.  
No risk factors were identified in 37 (26.8%)cases. 
One or more risk factors were identified in 101 (73.2%) cases. 
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PRESENTING SYMPTOMS. 
 
 
Classic triad of ectopic pregnancy was seen only in 44 cases. 
Gastrointestinal symptoms , urinary symptoms  and  vaso vagal 
symptoms were reported  in some cases. 
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amenorrhoea amenorrhoea,bleeding p/v
amenorrhoea,bleeding p/v,anuria amenorrhoea,pain
amenorrhoea,pain,bleeding p/v amenorrhoea,pain,diarrhoea
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amenorrhoea,pain,oliguria amenorrhoea,pain,vomiting
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CLINICAL SYMPTOMS 
 
S.NO CLINICAL SYMPTOMS 
NO OF 
PATIENTS 
Percentage 
out of 138 
pts 
1 Amenorrhoea  100 72.5 
2 Abdominal pain 131 94.9 
3 Bleeding  p/v 59 42.8 
4. Amenorrhoea , abdominal pain 94 68.1 
5 Amenorrhoea , bleeding p/v 47 34.1 
6 Abdominal pain , bleeding p/v 56 40.1 
7 Amenorrhoea , abdominal pain ,  
bleeding p/v 
44 31.9 
8  Vaso vagal symptoms 10 7.2 
9 Gastro intestinal symptoms 11 8.0 
10 Urinary symptoms  3 2.2 
11 Anasarca , breathlessness 1 0.7 
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PULSE RATE 
Tachycardia was present in 71(51.4%) patients. 
PULSE VOLUME 
Pulse volume No of patients percentage 
Normal  129 93.5 
feeble 9 6.5 
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BLOOD PRESSURE 
Blood pressure in 
mmHg 
No of Patients Percentage 
<  90/60 17 12.3 
90/60 or more 121 87.7 
 
Hypotension was present  in  17 (12.3%) patients. 
Among them 9 (6.5%) patients were presented with shock. 
HAEMOGLOBIN LEVEL 
 
67 (48.6%) patients had 3 to 5 gm% of Hb. 
41 (29.7%) patients had  Hb concentration  between  5.1 to 7 gm%. 
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In total , 108 (78.3%) patients were severely anaemic. 21 (15.2%) 
patients  were  moderately  anaemic. 1 (0.7%)  patient was  mild  
anaemic. 8 ( 5.8%)  patients  were  not anaemic. 
 
SERUM BETA hCG 
 
Sr. beta hCG was not done in 121 ( 87.7%)  patients . Sr. beta hCG  
was done  in 17 (12.3%) patients  with doubtful diagnosis. Among them 
13 patients(9.4%) had value  of  < 5,000  IU/ L and  4 (2.9%)  patients 
had >5,000 IU / L. 
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PER ABDOMINAL EXAMINATION FINDINGS 
 
46 (33.3%)   patients  had  no abdominal findings . Others had one 
or more abdominal findings as mentioned above. 
Abdominal distension was present in 57 (41.3%)  patients . 
Abdominal tenderness / guarding was present in 78 (56.5%) 
patients . 
Abdominal distension with tenderness / guarding was present in 43 
(31.2%) patients .  
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PER VAGINAL EXAMINATION FINDINGS  
 
On per vaginal examination 38 ( 27.5%) patients had no positive 
findings . Others had one or more positive findings as mentioned above . 
Forniceal fullness was present in 39 ( 28.3%) patients. 
Forniceal tenderness was present in 79 (57.2%) patients . 
Adnexal mass was present in 3 ( 2.8% ) patients. 
Forniceal fullness and tenderness was present in 19 (13.8%) 
patients .  
Forniceal tenderness and adnexal mass was present in 2 (1.4%) 
patients .  
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CERVICAL EXCITATION TEST 
Cervical excitation test was done in all 138 patients. 
Cervical excitation 
test 
No  of  patients Percentage 
Positive  100 72.5 
negative 38 27.5 
total 138 100 
 
 
Culdocentesis was not done in 99 (71.7%) patients .  
Culdocentesis was done in 39 (28.3%) patients . Among them  38 
(27.5%)  patients were positive  and  1 ( 0.7%) patient was negative .  
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ULTRASOUND FINDINGS 
Routine ultrasound examination  including  both transabdominal 
and transvaginal scans were done in all patients on admission . 
Ultrasound findings No of patients Percentage 
Empty uterus , adnexal mass 15 10.9 
Empty uterus , free fluid 34 24.6 
Empty uterus , adnexal mass , free fluid 68 49.2 
Normal study 2 1.4 
Bicornuate uterus with free fluid 1 0.7 
Bicornuate uterus with no G.sac 1 0.7 
Bicornuate uterus with G.sac in both horns 1 0.7 
Intra uterine G.sac with free fluid 1 0.7 
Empty uterus,Extra uterine G.sac with FP 
and FHR 
7 5.1 
Empty uterus,extra uterine G.sac with FP 
without FHR 
1 0.7 
Empty uterus, extra uterine G.sac without 
FP 
3 2.2 
Empty uterus with ovarian follicle 2 1.4 
IUCD in situ , adnexal mass, free fluid 1 0.7 
Empty uterus , adnexal mass ,localised fluid 
collection 
1 0.7 
Total 138  
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ADDITIONAL IMAGINGS 
 
In addition to routine ultrasound done in all patients ,  CT was taken in 
one patient , Doppler was done in 4 patients . MRI was taken in 3 patients 
. 
 
 
  
0
20
40
60
80
100
120
140
CT Doppler MRI not done
1 4 3
130
0.7 2.9 2.2
94.2
ADDITIONAL IMAGING
No of Cases Percentage
89 
 
CLINICAL DIAGNOSIS 
 
 
Clinical diagnosis was made after history taking , physical 
examination , urine pregnancy test , routine ultrasound examination and  
,if necessary additional imagings and culdocentesis in some cases. 
Clinical diagnosis was ectopic pregnancy in 137 ( 99.3%) patients 
and  heterotopic pregnancy in 1 ( 0.7%) patient .  
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TIME INTERVAL BETWEEN ADMISSION AND ONSET OF 
DEFINITIVE TREATMENT 
 
The definitive treatment by either laparotomy or medical 
management of  ectopic pregnancy  started within 2 hrs in 102 (73.9%) 
patients .  
Time delay  for more than 2 hrs was present in 36(26 %) patients . 
Definitive treatment was delayed for more than 3 days in 5 (3.6%) 
patients .  
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REASONS   FOR TIME  DELAY 
 
Most common cause of time delay was late diagnosis, which was 
present in 25 (18.1%) patients . 
Other causes for time delay are waiting for beta hCG report , 
admission in other wards and doubtful diagnosis . 
There was no time delay in 102 (73.9%) patients in whom 
definitive treatment started within two hours .  
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MEDICAL MANAGEMENT CRITERIA 
 
 
Medical management criteria was applicable in only 11 ( 8%) 
patients .  
Medical management criteria was not applicable in 127 (92%) 
patients .  
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MANAGEMENT 
Management No of patients Percentage 
Rt partial salphingectomy 21 15.2 
Rt total salphingectomy 19 13.8 
Lt partial salphingectomy 21 15.2 
Lt total salphingectomy 10 7.2 
RSO 10 7.2 
LSO 10 7.2 
RSO + LSO 1 0.7 
RSO + Lt salphingectomy 13 9.4 
LSO + Rt salphingectomy 3 2.2 
B/L total salphingectomy 16 11.6 
Rt cornual resection 2 1.4 
Removal of  Rt horn ectopic 1 0.7 
Hysterectomy 1 0.7 
Rt total salphingectomy + Rt ovarian 
cystectomy 
1 0.7 
Lt total salphingectomy + MVA 1 0.7 
Lt ovariotomy + D&C 1 0.7 
B/L ovarian cystectomy 1 0.7 
 Negative Laparotomy + D&C 1 0.7 
Medical management , MTX - 
multidose 
5 3.6 
Total 138  
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Medical management criteria was applicable in 11 patients . 
Medical management was done in 5 patients .  
Unilateral partial salphingectomy was done in 42 patients 
.unilateral total salphingectomy was done in 31 patients . B/L total 
salphingectomy was done in 16 patients. 
Unilateral salphingo oophorectomy was done in 36 patients. B/L 
salphingo oophorectomy was done in 1 patient. 
One patient had  hysterectomy . 
One patient had  negative  laparotomy . 
TYPES OF ECTOPIC PREGNANCY 
 
Per operatively 108 (78.3%) patients  were found to be having  
ruptured ectopic. 1 (0.7%) patient had  chronic ruptured ectopic . 
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17 (12.3%) patients had  unruptured ectopic .  
9 (6.5%) patients had tubal abortion .  
In remaining  3 ( 2.2%) patients , 1  patient  had  negative 
laparotomy  and  2 others  were found to be having  ovarian cyst per 
operatively . 
SIDE OF THE ECTOPIC PREGNANCY 
 
81 (58.7%) patients were found to be having  right sided  ectopic 
pregnancy . 
54 (39.1%) patients were found to be having  left sided ectopic 
pregnancy. 
In remaining  3 ( 2.2%) patients , 1  patient  had  negative 
laparotomy  and  2 others  were found to be having  ovarian cyst per 
operatively . 
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SITE OF THE ECTOPIC PREGNANCY 
 
Site No of patients percentage 
ampulla 60 43.5 
cornua 13 9.4 
fimbria 20 14.5 
isthmus 21 15.2 
infundibulum 3 2.2 
Entire tube 1 0.7 
ovary 11 8.0 
Rt horn 1 0.7 
Not applicable ( NA) 8 5.8 
total 138  
 
Most common site was ampulla followed by isthmus and fimbria .  
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Site could not be identified in medically managed patients.( 5 
patients). 
In remaining  3 ( 2.2%) patients , 1  patient  had  negative 
laparotomy  and  2 others  were found to be having  ovarian cyst per 
operatively . So site was not applicable in 8 patients (5+3). 
AMOUNT OF HAEMOPERITONEUM ( ml) 
Haemoperitoneum 
in ml 
No of patients percentage 
0-500 48 34.8 
501-1000 31 22.5 
1001-1500 23 16.7 
1501-2000 13 9.4 
2001-3000 4 2.9 
Nil 14 10.1 
NA 5 3.6 
total 138  
 
Amount of clotted blood were weighed  and converted into ml  to 
simplify the data collection and analysis .  
5 (3.6%) patients were managed medically. So per operative 
finding of haemoperitoneum was not applicable. 
In remaining 133 (96.4%)  patients , 40 (29%) patients had 
haemoperitoneum of more than one litre. 
14 (10.1%) patients had no haemoperitoneum .  
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OTHER PER OPERATIVE FINDINGS 
S.no Other per operative findings No of patients 
1 Nil 62 
2 e/o recanalisation 1 
3 Active bleeding 2 
4 Adhesions 26 
5 Cystic ovaries 7 
6 Haemorrhagic Rt ovary 1 
7 Uterine anomalies 3 ( 2-bicornuate,1- arcuate) 
8 Corpus luteal cyst 5(2-same side,3-opposite side) 
9 Fimbrial cyst 2 (opposite side) 
10 Endometriosis 1 
11 B/L hydrosalphinx 1 
12 Haematosalphinx 1 
13 B/L dermoid cyst 1 
14 Ovarian cyst 4 (1-complex, 
1-twisted, 
1-haemorrhagic, 
1-simple) 
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BLOOD AND BLOOD PRODUCTS TRANSFUSION 
No of units of blood & 
blood products 
No of patients 
nil 36 
1 WB 36 
2 WB 32 
3 WB 13 
4 WB 6 
1 WB,1 PCV 1 
2 WB, 1 PCV 1 
2 WB,2 PCV 1 
3 WB, 4 FFP 1 
3 WB,3 FFP 1 
4 WB,2FFP 2 
4 WB,4 FFP 2 
4 WB, 4 FFP,4 PLTS 1 
5 WB ,3 FFP 1 
5 WB,4 FFP,2 PLTS 1 
1 PCV 1 
2 PCV 2 
Total 138 
 
36 ( 26.1%)  patients required no blood transfusion. 
65 (47.1%) patients required more than one unit of  blood /  blood 
products transfusions. 
14 (10.1%) patients required more than 3 units of  blood / blood 
products transfusions. 
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 ICU CARE 
 
90 (65.2%)  patients required no ICU care. 
48 (34.8%) patients required  ICU care. Most of them required ICU care 
for one or two days.  
Only 4 (2.9%) patients required ICU care for more than 2 days .  
One patient required  ventilator support .  
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FEVER 
 
Among the study population  60 (43.5%) patients had fever , especially 
post operatively . 
78(56.5%) patients had no fever during the hospital stay .  
DURATION OF HOSPITAL STAY 
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Most of the patients  were discharged  on 7th  or 8th  post operative 
day after suture removal. 
126 (91.3%) patients were discharged within 10 days. 
12 (8.7%) patients required  prolonged hospital stay for more than 
10 days. 
FINAL DIAGNOSIS 
 
Out of 138 patients , the final diagnosis of ectopic pregnancy was 
made in 129 patients ,which was confirmed by HPE reports in 124 
patients. 5 patients underwent medical treatment . So,tissue was not 
available for HPE diagnosis. But all 5 patients were responded  to 
medical management and treated successfully. 
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 corpus luteal cyst was diagnosed in 3 patients only after HPE 
reports. 
1 patient had dermoid cyst, which was confirmed by HPE. 
Location of pregnancy was not identified in one patient. 
Heterotopic pregnancy was confirmed by HPE in one patient . 
1 patient was diagnosed to be having  an ovarian cyst  per 
operatively. 
Final diagnosis of ovarian cyst was made in 2 patients only after 
HPE report . 
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SENSITIVITY , SPECIFICITY,POSITIVE AND NEGATIVE 
PREDICTIVE VALUES OF SYMPTOMS FOR DIAGNOSING 
ECTOPIC PREGNANCY 
Patient’s                    ectopic               sensitivity    specificity     PPV          NPV 
Symptoms               pregnancy 
                              yes            no 
amenorrhoea 
        yes                 95             5                 73.6             44.4             95.0       10.5 
        no                  34             4 
abdominal pain 
        yes               124             7                   96.1           22.2             94.7       28.6 
        no                 5                 2 
bleeding p/v 
       yes                 59               0                  45.7           100              100         11.4 
       no                  70               9 
ameno – pain 
        yes               90               4                    69.8           55.6            95.7        11.4 
        no                 39              5 
ameno- bleed p/v 
        yes               47               0                    36.4           100             100           9.9                
        no                82               9                          
pain-bleed p/v 
       yes               56              0                     43.4             100            100         11.0                                   
       no                73              9       
class-triad 
       yes              44               0                    34.1              100           100          9.6                                        
       no               85               9             
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SENSITIVITY , SPECIFICITY,POSITIVE AND NEGATIVE 
PREDICTIVE VALUES OF SYMPTOMS FOR DIAGNOSING 
ECTOPIC PREGNANCY 
Patient’s            ectopic        sensitivity    specificity     PPV          NPV 
Symptoms        pregnancy 
                         yes            no 
amenorrhoea 
        yes                 95             5                 73.6             44.4             95.0       10.5 
        no                  34             4 
abdominal pain 
        yes               124             7                   96.1           22.2             94.7       28.6 
        no                 5                 2 
bleeding p/v 
       yes                59               0                   45.7           100              100         11.4 
       no                 70               9 
ameno – pain 
        yes              90               4                     69.8           55.6            95.7        11.4 
        no                39              5 
ameno- bleed p/v 
        yes              47               0                     36.4           100             100           9.9                
        no               82               9                          
pain-bleed p/v 
       yes              56              0                      43.4             100            100         11.0                                   
       no               73              9       
class-triad 
       yes             44               0                     34.1              100           100          9.6                                        
       no              85               9             
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SENSITIVITY , SPECIFICITY,POSITIVE AND NEGATIVE 
PREDICTIVE VALUES OF EXAMINATON FINDINGS FOR 
DIAGNOSING ECTOPIC PREGNANCY 
Examination              ectopic               sensitivity    specificity     PPV          NPV 
findings                  pregnancy 
                              yes            no 
abd  distension 
        yes                55             2                42.6              77.8            96.5          8.6                                     
        no                 74             7                     
abd tenderness 
or guarding 
        yes               74            4                 57.4               55.6            94.9          8.3                                            
        no                55            5                         
abd distension 
&tenderness   
or guarding 
       yes             42               1               32.6               88.8               97.7         8.4                                                    
       no              87              8                               
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SENSITIVITY , SPECIFICITY,POSITIVE AND NEGATIVE 
PREDICTIVE VALUES OF  P/V FINDINGS FOR DIAGNOSING 
ECTOPIC PREGNANCY 
Per vaginal                ectopic              sensitivity    specificity     PPV          NPV 
findings                   pregnancy 
                               yes            no 
forniceal 
 fullness 
        yes                 36             3                27.9               66.7          92.3        6.1                                                    
        no                  93             6                                              
forniceal  
tenderness 
        yes               75              4                 58.1               55.5          94.9         8.5                                                
        no                54              5                            
adnexal mass 
       yes               3                 0                 2.3                100             100         6.7                                                    
       no              126               9                                            
f.fullness & 
tenderness 
        yes             19              0                 14.7                 100            100         7.6                                      
        no              110            9                                  
f.tenderness  
& adnex.mass 
        yes            2                 0                     1.4                100            100          6.6                                  
        no             127             9                                      
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SENSITIVITY , SPECIFICITY,POSITIVE AND NEGATIVE 
PREDICTIVE VALUES OF  ULTRASOUND  FINDINGS FOR 
DIAGNOSING ECTOPIC PREGNANCY 
 
Ultrasound              ectopic              sensitivity    specificity     PPV          NPV 
findings                   pregnancy 
                               yes            no 
 
empty ut & 
adnex.mass 
        yes               13              2              10.7           77.8             86.7           5.7                                                         
        no                116             7                                               
empty ut &  
free fluid 
        yes              33              1              25.6             88.9            97.1            7.6                                       
        no               96              8                                         
empty ut , 
adnex.mass 
& free fluid 
       yes              64               4                52.7              55.6           94.1           7.1                                                  
       no                65              5                                         
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SENSITIVITY , SPECIFICITY,POSITIVE AND NEGATIVE 
PREDICTIVE VALUES OF  UPT  AND CEVICAL EXCITATION 
TEST FOR DIAGNOSING  ECTOPIC PREGNANCY 
Examination             ectopic              sensitivity    specificity     PPV          NPV 
findings                   pregnancy 
                               yes            no 
 UPT 
     positive               127           5               98.4           44.4             96.2          66.7                                            
     negative                 2            4            
cervical 
excitation  
test 
     positive               96            4              74.4           55.6             96.0           13.2                                              
     negative              33            5      
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GESTATIONAL AGE AT RUPTURE FOR SPECIFIC SITES 
 <  35 
days 
n (%) 
36-56 
days 
n (%) 
>  57 
days 
n (%) 
Not 
known 
n (%) 
Total 
n (%) 
 
Ampulla 5 (4.5) 32 (29.4) 6 (5.5) 5 (4.5) 48 (43.9) 
Fimbria 2 (1.8) 6 (5.5) 6 (5.5) 3 (2.8) 17 (15.6) 
Isthmus 1 (0.9) 11 (10.1) 4 (3.7) 4 (3.7) 20 (18.4) 
Infundibulum 0 (0) 1 (0.9) 1 (0.9) 0 (0) 2 (1.9) 
Ovary 2 (4.8) 5 (4.5) 1 (0.9) 1 (0.9) 9 (8.3) 
Cornua 1 (0.9) 3 (2.8) 5 (4.5) 3 (2.8) 12 (11.0) 
Rudimetary horn 0 (0) 0 (0) 1 (0.9) 0 (0) 1 (0.9) 
Total 11 (10.1) 58 (53.2) 24 (22) 16 (14.7) 109 (100) 
    
Total no of  ruptured ectopic was 109 including 1 chronic ruptured 
ectopic .   
Most of the ectopic pregnancies  were found to be ruptured 
between 6 to 8 weeks. 
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> 1.5 L OF  HAEMOPERITONEUM FOR SPECIFIC SITES OF 
ECTOPIC  PREGNANCY 
 No of cases Percentage 
Ampulla 7 29.15 
Isthmus 7 29.15 
Fimbria 1 4.20 
Cornua 9 37.50 
Total 24 100.00 
 
Ruptured Cornual ectopic pregnancies were  most commonly 
associated with  massive haemoperitoneum followed by isthmic and 
ampullary pregnancies . 
MORBIDITIES ASSOCIATED WITH RUPTURED AND 
UNRUPTURED ECTOPIC PREGNANCIES 
 Ruptured  Unruptured Tubal abortion 
Total no of  cases 109 17 9 
Fever 56 1 3 
Anaemia 43 1 0 
 
Ruptured  ectopic  pregnancies  were  associated  with  higher  
morbidities. 
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DISCUSSION 
In the present study, the incidence of ectopic pregnancy was 8.7 
per 1000 deliveries. In a study conducted by shraddha shetty k et. al in 
mangalore , the incidence was 5.6/1000 deliveries[6] . In a study conducted 
by Rashmi et.al the incidence was 1: 399 pregnancies [7] . In a study 
conducted by porwal sanjay et al , the incidence was found to be 2.46 per 
1000 deliveries[8] . 
Majority of the patients ( 63.8%) were in the age group of  21 to 30 
years in our study. Similar results were found in Smita singh et.al and 
Samiya Mufti et.al studies[70,65 ] . This corresponds to the age of peak 
sexual activity and reproduction . There are studies stating that age 
related tubal changes increase the incidence of ectopic pregnancy [63,64] . 
In our study multigravida ( 75.4%) were found to be more prone to 
have an ectopic pregnancy. This result was similar to other studies 
conducted by Shraddha Setty et.al and Laxmi karki et al[6,257] . In Laxmi 
karki study 61% were multiparous women. 
Majority  (54.3%) of the patients presented with  5 to 8 weeks of 
amenorrhoea representing the time period required for the growing 
ectopic gestation to distend the tube and cause symptoms . This results 
are consistent with those from Tang BD et.al and Panti A et.al[10,13] . 
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Among the nulliparous women 62.5% had history of subfertility 
for more than one year .Similar findings were obtained in Tanveer 
Shafquat et.al study[99 ]. 
The commonest risk factors among the study population were 
previous LSCS,  tubal surgeries , previous ectopic pregnancies , prior 
H/O abortions , H/O infertility  and pelvic inflammatory disease. Similar 
risk factors were noted in various other studies[6,8] . The increasing trend 
in caesarean section was found to be associated with increased risk of 
ectopic pregnancy .  6 patients had  H/O MTP pills intake. The 
significance of this risk factor needs further studies . 7 patients gave 
history of ovulation induction . Advancement in infertility treatment was 
associated with significant risk of ectopic pregnancy.  
In our study 25 ( 18.1%) cases were post sterilisation ectopic 
pregnancies. Among the sterilisation methods, concurrent and puerperal 
sterilisation were found to be associated with higher number of ectopic 
pregnancies. Ectopic pregnancies most commonly occurred 3 to 10 years 
after the sterilisation surgery. 
The most common presenting symptom was abdominal pain which 
was found in 94.9% of patients , followed by amenorrhoea in 72.5% of 
the patients. The classic triad was present only in 31.9% of cases . In 
porwal sanjay et al study , 90% reported amenorrhoea and 87.5% 
reported abdominal pain [8]. In some cases gastrointestinal and vaso vagal 
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symptoms are the presenting complaints. In our study the classic triad  
has 100 % specificity and positive predictive value , but low sensitivity . 
The most common examination findings were tachycardia ( 51.4%) 
and hypotension (12.3%) . 6.5% of the patients presented with shock. 
Tachycardia was not present in all cases of ruptured ectopic pregnancy. 
48.6% of patients were severely anaemic with Hb less than 5 gms%. 
In per abdominal examination  abdominal tenderness (56.5%) was 
the most common finding. In per vaginal examination forniceal 
tenderness (57.2%) was the most common finding. Cervical excitation 
test was positive in 72.5%. Culdocentesis was done only in 39 patients. 
Among them 38 were positive. In p/v  the presence of adnexal mass has 
highest specificity and positive predictive value (100%) . 
Urine pregnancy test  and ultrasound examination were done in all 
patients. Serum  beta hCG was sent only in haemodynamically stable 
patients with unruptured ectopic pregnancy to decide for medical 
management and  in doubtful cases. UPT has highest (98.4%) sensitivity, 
but the specificity was low. In ultrasound examination empty 
uterus,adnexal mass and free fluid were strongly suggestive of ectopic 
pregnancy, especially in the presence of positive UPT. 
Medical management criteria was applicable in 11 patients. Among 
them only  5 patients had medical management. Remaining were 
multiparous women who wanted definitive surgery rather than medical 
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management. Multi dose methotrexate regimen was used in all 5 patients 
and were treated successfully. 
Treatment delay for more than 2 hrs was present in 36 (26%) 
patients.  The most common reason for time delay was late diagnosis of 
ectopic pregnancy .In these cases diagnosis was misguided by atypical 
presentation, wrong referral diagnosis and atypical ultrasound findings. 8 
patients had admitted in wrong wards and then transferred to O &G ward 
. Time delay was found to be associated with more morbidity. 
In surgically managed group all 132 patients underwent 
laparotomy. Total/partial salphingectomy and salphingo oophorectomy 
were the common surgeries performed. In developing countries open 
method by laparotomy still remains the most commonly used 
management for ectopic pregnancy. But the trend is changing towards the 
laparoscopic surgery and conservative management. In Samiya Mufti 
et.al study the surgical management was by open method in all cases [65]. 
During laparotomy 109 ( 79%) cases were found to be ruptured 
including one chronic rupture. In developing countries still majority of 
cases present late with rupture. This was evidenced by many studies[6,7,65]. 
Ampulla was the most common site of the ectopic pregnancy found 
in 43.5% of the patients . This result was similar to other studies [7,70]  . 
During laparotomy 124 patients  were found to be having ectopic 
pregnancy. One patient was found to be having  a rare variety  of 
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pregnancy known as heterotopic pregnancy. One patient had negative 
laparotomy. One patient was found to be having dermoid cyst. One 
patient had ovarian cyst. Remaining 5 patients were diagnosed as ectopic 
pregnancy per operatively, then diagnosis was changed to gynaec lesions 
( 3 corpus luteal cyst and 2 simple  ovarian cyst) after HPE report. 
Additional findings during laparotomy were corpus luteal cyst in 5 
patients, fimbrial cyst in 2 patients , uterine anomalies in 3 patients, 
ovarian pathology in 13 patients, endometriosis , haematosalphinx and 
hydrosalphinx each in 1 patient. Adhesions were found in 26 patients. 
Only one patient had hysterectomy for uncontrolled bleeding from 
the ruptured site of  cornual ectopic pregnancy . Only one patient required 
post operative ventilatory support. No maternal mortality was found 
during the study period. This result was consistent with Rashmi et.al 
study[7] . 
40 (29%) patients had haemoperitoneum of more than one litre. 
65(47.1%) patients required  more than one unit of blood transfusion 
.Massive haemoperitoneum was most commonly found in cornual and 
isthmic ruptured ectopic pregnancies. 
Post operative anaemia and fever were found to be more common 
in ruptured ectopic pregnancies when compared to unruptured ectopic 
pregnancies. 
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12 (8.7%) patients required prolonged hospital stay for more than 
10 days. The factors associated with prolonged hospital stay were 
medical management , anaemia correction , post operative fever and late 
diagnosis. 
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CONCLUSION AND RECOMMENDATIONS 
1. Ectopic pregnancy is famous for its diversity of clinical presentations 
and atypical presentations. Strong suspicion is required for its early 
diagnosis. 
2. Amenorrhoea is not necessary for the diagnosis of ectopic pregnancy. 
UPT and ultrasound should be advised to all reproductive age group 
patients presenting with abdominal pain , bleeding p/v with or without 
amenorrhoea. 
3. Sterilisation could not rule out the possibility of an ectopic pregnancy. 
So, we should advise the patients to come for check up if she misses 
the periods as early as possible. 
4. The recommended sterilisation techniques should be followed strictly. 
5. To join the global trend of conservative management for ectopic 
pregnancy, early diagnosis before rupture is important. 
6. Ultrasound is the simple and gold standard diagnostic method for 
ectopic pregnancy in low resource settings. 
7. Routine first trimester ultrasound should be done in all pregnant 
women at the booking visit itself . 
8. UPT kits and sonographic equipments should be made available in all 
primary health centres and emergency gynaecological units. 
9. Staffs should be trained adequately to use and interpret the 
sonographic images. 
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10. Early diagnosis and referral is the key factor in reducing the maternal 
morbidity and in preserving the future fertility. 
11. Because of the high incidence of tubal rupture in our set up, 
community education is required to inform the women to attend the 
health facilities as early as possible once they have symptoms . 
 
 
 
 
DATA SHEET 
PATIENT PROFILE 
Name :                                                     Age :                               I.P.no : 
Address     : 
Socio economic status   : 
Date and time of admission  : 
Mode of admission   :  Referral /Self 
In case of  referral the referral diagnosis : 
Mode of transport    : 
Obstetric code    : 
LMP      : 
Period of amenorrhoea   : 
UPT       :     Positve/ Weakly positive/ Negative 
Married since    : 
Duration of subfertility   : 
Past obstetric history   : 
 Miscarriage 
 Normal vaginal delivery 
 Caesarean section 
 Previous ectopic gestation 
 Gestational trophoblastic disease 
Sterilisation status    : 
       Sterilised / not sterilised  
If sterilised , by what method 
        1) Concurrent sterilisation 
        2) Puerperal sterilisation 
        3) Laparoscopic sterilisation 
        4) TAT by open method 
 
  
TIME SINCE STERILISATION : 
OTHER CONTRACEPTIVE USE : 
       1) Barrier method 
       2) Intra uterine devices 
       3) Oral contraceptive pills 
                   Combined pills / POP / Emergency contraceptive pills 
       4) Others  
RISK FACTORS : 
          Previous LSCS 
          H/O abortion 
          H/O infertility 
         Ovulation induction 
          Artificial Reproductive techniques.             
          Previous ectopic pregnancy 
         Pelvic inflammatory diseases               
          Sterilisation 
          Tubal recanalisation surgery 
          Other pelvic surgeries            
          Intrauterine contraceptive device use 
          Combined oral contraceptive pills 
          Progesterone only pills 
          Emergency contraceptive pills 
          MTP pills 
          Smoking 
          Others                     
  
PRESENTING SYMPTOMS : 
        Abdominal pain 
        Amenorrhoea 
        Bleeding p/v 
        Vasovagal symptoms 
        Gastro intestinal symptoms 
        Shoulder tip pain  
        Others  
EXAMINATION : 
        Puse rate 
        Pulse volume 
        Blood pressure 
        Temperature 
        Consciousness 
        Pallor 
       Tachycardia 
PER ABDOMINAL FINDINGS 
          Abdominal distension 
          Abdominal tenderness 
          Guarding  
PER VAGINAL EXAMINATION 
          Forniceal tenderness 
          Forniceal fullness 
          Adnexal mass 
          Others 
CERVICAL EXCITATION TEST :   positive / negative 
CULDOCENTESIS    :   positive / negative / not done 
  
INVESTIGATIONS 
          Haemoglobin 
          Renal function test 
          Liver function test 
          Blood grouping & typing 
          Serum beta hCG 
ULTRASOUND   :  Transabdominal / Transvaginal / Both 
ULTRASOUND FINDINGS : 
         Empty uterus 
         Free fluid 
         Adnexal mass with size 
         Extra uterine gestational sac with size 
         Embryonic cardiac activity 
         Other findings   
OTHER IMAGINGS : Doppler scan /CT/ MRI / not done 
CT/ MRI /Doppler findings , if taken  : 
CLINICAL DIAGNOSIS   : 
TIME INTERVAL BETWEEN ADMISSION AND ONSET OF 
DEFINITIVE TREATMENT   : 
TIME DELAY : yes / no 
REASONS FOR TIME DELAY 
                  1) Late diagnosis 
                  2) Waiting for beta hCG / CT/MRI reports 
                  3) Admissions in other wards 
                  4) Doubtful diagnosis 
                  5) others 
MANAGEMENT    : Medical / Surgical 
MEDICAL MANAGEMENT  :   Single dose MTX / Multiple dose MTX 
SURGICAL MANAGEMENT  : Laparotomy / Laparoscopic 
 
Date and time of surgery : 
Type of surgery : 
       1) Partial salphingectomy – unilateral / bilateral 
       2) Total salphingectomy – unilateral / bilateral 
       3) Salphingo oophorectomy 
       4) Salphingostomy 
       5) Hysterectomy                   
       6) Cornual wedge resection 
       7) Others 
Per operative findings : 
       1) Rupured / unruptured / chronic rupture / tubal abortion 
       2) Side 
       3) Site 
       4) Amount of haemoperitoneum 
       5) Other findings 
                  Adhesions 
                  Corpus luteal cyst – same side / opposite side 
                  Ovarian cyst 
                  Uterine anomalies                     
                  Endometriosis 
                  Tubal pathology                       
                  Other findings 
 Duration of surgery : 
Complications during surgery : 
NUMBER OF UNITS OF BLOOD AND BLOOD PRODUCTS 
TRANSFUSED : 
ICU CARE ( In days ) : 
VENTILATORY SUPPORT REQUIRED / NOT 
FEVER : Present / Absent 
DURATION OF HOSPITAL STAY ( IN DAYS): 
HPE REPORT   : 
FINAL DIAGNOSIS  : 
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late diagnosis
N
A
RSO
,Lt salphingectom
y
U
R
Rt
ovary
nil
nil
1W
B
nil
AB
17
ectopic
41
radha
23
7976
06.02.13
G
2P1L1
N
K
N
K
P
N
A
N
S
N
A
N
A
IU
CD
IU
CD
LAP
120/70
76
9
N
D
nil
nil
N
N
D
EU
,Lt A. cyst of 5cm
N
D
ectopic 
5 hrs
late diagnosis
N
A
Lt ovariotom
y,D&
C
N
A
N
A
N
A
nil
Lt ovary enlarged,cystic
nil
nil
AB
7
ovarian cyst
42
lakshm
i
29
9622
13.02.13
G
3P2L2
09.01.13
35
P
N
A
N
S
N
A
N
A
EC
em
.pills
LAP,BPV
110/70
126
12
N
D
T
FT,FF
P
N
D
EU
,Rt A. cyst ,FL
N
D
ectopic 
30 m
in
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
ovary
200
fresh oozing from
 Rt ovary
nil
nil
AB
7
ectopic
43
am
utha
27
10352
17.02.13
G
2P1L1
02.01.13
46
P
N
A
N
S
N
A
N
A
nil
nil
AM
,LAP
110/70
86
8.8
N
D
nil
nil
N
N
D
EU
,Lt &
Rt A. m
ass,FL
N
D
ectopic 
4hrs 30 m
in
late diagnosis
N
A
LSO
R
Lt
ovary
800
Rt ovary cystic
2 W
B
nil
PR
8
ectopic
44
m
uppidathy
32
13342
02.03.13
G
3P2L2
26.01.13
35
P
N
A
N
S
N
A
N
A
nil
M
TP pills
AM
,LAP,BPV
100/60
92
8.2
N
D
D,T
FT
P
P
EU
,Rt A. m
ass, FL
N
D
ectopic 
20 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
100
nil
nil
nil
AB
7
ectopic
45
am
utha
25
14319
07.03.13
G
2P1L1
19.01.13
57
P
N
A
N
S
N
A
N
A
nil
nil
AM
,LAAP,BPV
100/60
88
9.6
N
D
D,T
FT
P
N
D
EU
,Rt A. m
ass, FL
N
D
ectopic 
20 m
in
N
A
N
A
RSO
R
Rt
Am
pulla
300
nil
1W
B
nil
PR
8
ectopic
46
stella
26
14677
09.03.13
G
6P2L2A3
24.01.13
44
P
N
A
S
4Y
TAT
N
A
abortions,tubal sx
AM
,LAP
120/80
84
13
N
D
T
FT
P
N
D
EU
,Lt A. m
ass,FL
N
D
ectopic 
1 hr
N
A
N
A
B/L total salphingectom
y
tubal abortion
Lt
fim
bria
50
nil
nil
nil
PR
7
ectopic
47
m
ariam
m
al
27
15413
12.03.13
G
2P1L1
21.01.13
50
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP
80/50
96
7.2
N
D
D
FT,FF
P
P
EU
,FL
N
D
ectopic 
20 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
1300
nil
3W
B
1day
PR
8
ectopic
48
lakshm
i
27
15689
14.03.13
G
4P2L2A1
06.02.13
36
P
N
A
S
7Y
LS
N
A
 abortion,tubal sugery
LAP
110/70
76
12
N
D
T
FT,FF
P
N
D
EU
,Lt A.m
ass,FL
N
D
ectopic 
40 m
in
N
A
N
A
B/L total salphingectom
y
R
Lt
Am
pulla
500
nil
1W
B
nil
PR
7
ectopic
49
chandra
29
17312
21.03.13
prim
i
16.01.13
64
P
10y
N
A
N
A
N
A
nil
ART
AM
,LAP,BPV
80/50
108
8.2
N
D
D,T
FF
P
P
EU
,FL
N
D
ectopic 
30 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
1500
nil
2 W
B,1PCV
2 days
PR
9
ectopic
50
usha
28
17787
24.03.13
G
3A2
N
K
N
K
P
8y
N
A
N
A
N
A
nil
abortions
LAP,BPV
110/60
102
8.6
N
D
D,T
FF
P
P
EU
,FL
N
D
ectopic 
20 m
in
N
A
N
A
Lt total salphingectom
y
R
Lt
isthm
us
1500
nil
3W
B
2 days
PR
8
ectopic
Sl.No
N
am
e
Age( in years)
I.P.No
D.O.A
Obstetric Code
LM
P
Period of 
Amenorrhoea (in 
Days)
UPT
Duration of 
Subfertility 
Sterlisation Status
Time Since ST 
(Years)
Method of ST
Other Contra 
Ceptive Use
R
isk Factors
Clinical 
Symptoms
B.P( in mmHg)
P.R( per minute)
Hb %
Sr.β HcG( M 
IU/ml)
P/A Findings
P/V Findings
Cervix Excitation 
Test
Culdocentesis
Ultrasound 
Findings
Additional Imaging 
Clinical Diagnosis
Time Interval 
Between Admission 
and Onset of 
definitive 
Treatment
Time Delay Due to
Medical 
Management 
Criteria 
Management
Ruptured (R) / 
Unruptured (UR)
Side
Site
Haemoperitoneum 
(in ml)
Other Findings
No.Of Units of 
Blood / Blood 
Products 
Transfusion
 ICU Care
Fever
Duration of 
Hospital Stay (in 
Days)
Final  
Diagnosis/HPE 
report 
51
saravanapriya
27
18653
28.03.13
prim
i
12.02.13
44
P
nil
N
A
N
A
N
A
nil
nil
AM
,LAP,BPV
110/80
86
8.8
N
D
D,T
FT
P
P
Bicorn.ut, FL
N
D
ectopic 
21 hrs
late diagnosis
N
A
Lt partial salphingectom
y
tubal abortion
Lt
Am
pulla
150
arcuate uterus
1 W
B
nil
AB
7
ectopic
52
pattathy
35
21384
09.04.13
G
3P2L2
N
K
N
K
P
N
A
N
S
N
A
N
A
nil
nil
LAP.BPV
110/70
106
7.6
N
D
D
nil
N
P
EU
,Lt A. m
ass,FL
N
D
ectopic 
7 hrs
sx side adm
n
N
A
Lt total salphingectom
y
R
Lt
isthm
us
800
nil
2W
B
nil
PR
13
ectopic
53
m
uhabath nisha
22
22994
15.04.13
G
2P1L1
N
K
N
K
N
N
A
N
S
N
A
N
A
nil
M
TP pills
LAP
120/70
76
7.8
N
D
T
FT
P
N
D
EU
,Rt A. m
ass of 4.5 cm
N
D
ectopic 
20 m
in
N
A
N
A
Rt total salphingectom
y
U
R
Rt
infundib
nil
nil
nil
nil
PR
10
ectopic
54
vasuki
28
24648
22.04.13
G
3P2L2
03.03.13
50
P
N
A
S
5Y
con
N
A
prev LSCS,tubal surgery
AM
,LAP
120/70
80
12
2010
nil
FT
P
N
D
EU
,Rt A. m
ass of 3.2 cm
N
D
ectopic 
2hrs
N
A
A
RSO
,Lt salphingectom
y
U
R
Rt
Am
pulla
nil
adhesions
nil
nil
AB
7
ectopic
55
m
uthu kum
ari
31
24737
22.04.13
G
5P2L2A2
N
K
N
K
P
N
A
S
1Y
con
 N
A
abortion, LSCS,tubal sx
LAP
90/60
88
11
N
D
D
FT
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
2hrs
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
fim
bria
300
adhesions
1W
B
nil
AB
7
ectopic
56
usharani
28
24916
23.04.13
G
3P2L2
14.03.13
40
P
N
A
S
3Y
PS
N
A
tubal surgery
AM
,LAP
120/80
86
11
N
D
T
FT
P
N
D
EU
,Lt A. m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
LSO
,Rt salphingectom
y
R
Lt
Am
pulla
500
adhesions
1W
B
nil
PR
8
ectopic
57
m
uthuselvi
22
26913
02.05.13
G
2P1L1
05.03.13
58
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP
110/80
88
9.8
N
D
T
FT
P
N
D
EU
,Rt A.m
ass,FL
N
D
ectopic 
1 hr 15 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
isthm
us
550
nil
1W
B
nil
AB
7
ectopic
58
vasanthi
30
30231
16.05.13
G
3P1L1A1
N
K
N
K
P
N
A
N
S
N
A
N
A
nil
prev ectopic, prev LSCS
LAP
110/70
84
10
N
D
T
FT,FF
P
P
EU
,Lt A. m
ass,FL
N
D
ectopic 
30m
in
N
A
N
A
Lt total salphingectom
y
R
Lt
Am
pulla
500
Rt tube absent
1W
B
nil
PR
8
ectopic
59
m
uthulakshm
i
31
30380
17.05.13
G
2P1L1
13.04.12
34
P
N
A
N
S
N
A
N
A
nil
prev LSCS
LAP,BPV
100/70
82
9
2126
T
FT
P
P
EU
,Lt A. m
ass,FL
N
D
ectopic 
40 m
in
N
A
N
A
LSO
R
Lt
Am
pulla
400
adhesions
1W
B
nil
PR
8
ectopic
60
Elizabeth
23
32383
26.05.12
G
2P1L1
07.04.13
49
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP
120/80
78
11.7
N
D
nil
FF
P
N
EU
,FL
N
D
ectopic 
1 hr
N
A
N
A
Lt total salphingectom
y
tubal abortion
Lt
fim
bria
100
nil
nil
nil
PR
8
ectopic
61
subbulakshm
i
23
33904
28.05.13
prim
i
28.03.13
61
P
6m
N
A
N
A
N
A
nil
PID
AM
,LAP
90/60
114
7.7
N
D
D,T
FF,FT
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
RSO
R
Rt
fim
bria
1500
ovary w
as adherent
3 W
B
2days
PR
9
ectopic
62
shanthi
34
36434
14.06.13
G
5P3L3A1
05.05.13
40
P
N
A
S
3Y
TAT
N
A
abortion,LSCS,tubal sx
AM
,LAP
120/70
108
8.1
N
D
T
FT
P
P
EU
,FL
N
D
ectopic 
30 m
in
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
ovary
300
e/o ST on both sides
2W
B
nil
PR
8
corpus luteal cyst
63
selvi
28
37925
21.06.13
prim
i
01.05.13
51
P
6y
N
A
N
A
N
A
CO
C
O
CP
AM
,LAP,BPV
130/70
92
6.8
N
D
T
FT,FF
P
P
EU
,Lt A. m
ass,FL
N
D
ectopic 
35 m
in
N
A
N
A
Lt total salphingectom
y
R
Lt
fim
bria
800
nil
2W
B
nil
AB
8
ectopic
64
subbulakshm
i
29
38381
24.06.13
G
4P1L1A2
14.05.13
41
P
N
A
N
S
N
A
N
A
IU
CD
 abortions
AM
,LAP,vom
it
80/40
>120,F
5.9
N
D
D,T
FT
P
P
EU
,FL
N
D
ectopic 
20 m
in
N
A
N
A
Lt partial salphingectom
y
R
Lt
Am
pulla
1900
nil
4W
B,4FFP
2 days
PR
10
ectopic
65
subbulakshm
i
22
38771
26.06.13
prim
i
11.05.13
46
P
2y
N
A
N
A
N
A
nil
nil
AM
,LAP
110/80
86
10
N
D
T
FT,FF
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
25 m
in
N
A
N
A
Rt partial salphingectom
y 
R
Rt
Am
pulla
250
nil
1W
B
nil
PR
8
ectopic
66
selvi
37
39089
27.06.12
G
3P2L2
N
K
N
K
P
N
A
N
S
N
A
N
A
nil
nil
LAP
130/80
78
11
5500
T
FT
P
N
D
EU
,Rt A.m
ass of 2.5cm
N
D
ectopic 
1 hr 30 m
in
N
A
N
A
Rt partial salphingectom
y
U
R
Rt
Am
pulla
nil
nil
nil
nil
AB
7
ectopic
67
thangam
ari
32
40629
04.07.13
G
3P2L2
25.05.13
40
P
N
A
S
6Y
con
N
A
prev LSCS,tubal sx
AM
,LAP,BPV
90/60
98
8
N
D
D,T
FT,FF
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
15 m
in
N
A
N
A
B/L total salphingectom
y
R
Rt
Am
pulla
1200
E/O
 ST on Lt side
2 W
B
1 day
PR
9
ectopic
68
latha
25
42080
11.07.13
G
2P1L1
N
K
N
K
P
N
A
N
S
N
A
N
A
nil
nil
LAP,BPV
110/70
96
7.4
N
D
T
FT
P
N
D
EU
,Rt A.m
ass,FL
N
D
ectopic 
4 hrs
late diagnosis
N
A
Rt cornual resection
R
Rt
cornua
2000
nil
3 W
B,4FFP
2 days
AB
8
ectopic
69
Vijaya
26
44210
22.07.13
G
2P1L1
02.06.13
50
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP,BPV
100/70
96
8.8
N
D
D,T
FF
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
30 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
700
nil
1W
B
nil
AB
8
ectopic
70
jeyabharathi
28
45074
26.07.13
G
2A1
27.05.13
60
P
3y
N
A
N
A
N
A
nil
prev ectopic
AM
,LAP
120/70
92
10.2
N
D
T
FT
P
N
D
EU
,FL
N
D
ectopic 
45 m
in
N
A
N
A
Lt partial salphingectom
y
R
Lt
Am
pulla
400
Rt ovary,tube-absent
1W
B
nil
PR
8
ectopic
71
boopathy
39
45652
29.07.13
G
4P3L3
29.05.13
61
P
N
A
N
S
N
A
N
A
IU
CD
IU
CD
AM
,LAP,BPV
120/70
82
10
N
D
T
FT
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
30 m
in
N
A
N
A
hysterectom
y
R
Rt
cornua
1500
nil
5W
B,4FFP,2PLTS
2 days
PR
10
ectopic
72
lakshm
i
34
46151
01.08.13
G
4P2L2A1
N
K
N
K
P
N
A
N
S
N
A
N
A
nil
abortion
LAP,giddi
130/60
100
6.4
N
D
D,T
nil
P
P
EU
,FL
N
D
ectopic 
16 hrs
sx side adm
n
N
A
B/L total salphingectom
y
R
Lt
isthm
us
1300
Rt fim
brial cyst
3W
B
1day
PR
8
ectopic
73
natchiyar
30
47757
09.08.13
G
3P2L2
21.06.13
49
P
N
A
N
S
N
A
N
A
IU
CD
IU
CD
AM
,LAP
120/70
104
7.5
N
D
D,T
FT
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
30 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
Am
pulla
1150
nil
2W
B
1 day
PR
8
ectopic
74
Jesintha
32
47634
08.08.13
P2L2
22.06.13
47
N
N
A
S
8Y
con
N
A
prev LSCS,tubal sx
AM
,LAP
120/60
96
6.9
N
D
T
FT
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
1 hr
N
A
N
A
RSO
R
Rt
ovary
150
adhesions,Rt ovarian cyst
1W
B
nil
PR
8
ovarian cyst
75
syedali fathim
a
34
47798
10.08.13
G
3P2L2
01.07.13
40
P
N
A
S
10Y
con
N
A
prev LSCS,tubal sx
AM
,LAP
100/70
120
10
N
D
D,T
FF
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
B/L total salphingectom
y
R
Lt
fim
bria
1350
Rt ovary adherent
2W
B
1day
PR
8
ectopic
76
bakkiyalakshm
i
27
49126
16.08.13
prim
i
25.06.13
52
P
6y
N
A
N
A
N
A
nil
ovulation induction
AM
,LAP
80/50
120
6.9
N
D
D,T
FT
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
15 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
Am
pulla
1600
nil
3W
B,3FFP
2 days
PR
8
ectopic
77
Rani
30
49284
17.08.13
G
4P3L3
20.06.13.
58
P
N
A
N
S
N
A
N
A
IU
CD
IU
CD
AM
,LAP
110/70
78
12
1156
nil
nil
P
N
D
EU
,Rt A. m
ass of 3 cm
N
D
ectopic 
6 hrs
 hCG
 report
A
M
edical, M
TX- m
ulti dose
U
R
Rt
N
A
N
A
N
A
nil
nil
AB
14
ectopic
78
valli
31
51516
28.08.13
G
2P1L1
10.07.13
49
P
N
A
N
S
N
A
N
A
PO
P
prev LSCS,PO
P
AM
,LAP,BPV
80/50
124
8
N
D
D,T
FF
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
cornua
1000
Rt corpus luteal cyst
4W
B
1 day
PR
9
ectopic
79
seevalam
uthu
40
51514
28.08.13
G
3P2L2
N
K
N
K
P
N
A
S
6Y
PS
N
A
PID,tubal surgery
LAP,BPV
120/70
96
7.6
N
D
D,T
FF
P
N
D
EU
,Lt A. m
ass,FL
N
D
ectopic 
1 hr
N
A
N
A
LSO
,Rt salphingectom
y
chr.R
Lt
fim
bria
500
adhesins
1W
B
nil
PR
8
ectopic
80
m
ariam
m
al
40
52172
01.09.13
G
3P1L1A1
11.07.13
52
P
N
A
N
S
N
A
N
A
nil
abortion,LSCS,PID
AM
,LAP,BPV
110/60
80
8.7
N
D
D,T
FT
P
N
D
EU
,Lt A.m
ass,FL
N
D
ectopic 
30 m
in
N
A
N
A
LSO
R
Lt
cornua
1100
ovary w
as adherent
2W
B
1 day
PR
8
ectopic
81
m
ani
30
54509
14.09.13
G
2P1L1
05.07.13
71
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP,BPV
110/80
88
10.3
N
D
T
FT
P
N
D
EU
,Rt A. m
ass of 4.5 cm
N
D
ectopic 
1 hr 30 m
in
N
A
N
A
Rt total salphingectom
y
U
R
Rt
Am
pulla
nil
nil
nil
nil
AB
7
ectopic
82
kanagavalli
30
55832
20.09.13
G
3P2L2
N
K
N
K
P
N
A
N
S
N
A
N
A
nil
nil
LAP,diarr
90/70
>120
4.5
N
D
D,T
FT
P
P
EU
,Lt A. m
ass,FL
N
D
ectopic 
15 m
in
N
A
N
A
Lt cornual resection
R
Lt
cornua
1500
nil
4W
B,2FFP
2 days
PR
9
ectopic
83
m
ariselvi
32
53957
11.09.13
G
2P1L1
27.07.13
46
P
N
A
N
S
N
A
N
A
nil
nil
AM
,LAP
100/60
80
10.4
N
D
nil
nil
P
N
D
Bicorn. ut w
ith G
.sac 
M
RI-heterotopic
heterotopic
9 days
late diagnosis
N
A
Lt total salphingectom
y,M
VA
R
Lt
Am
pulla
1100
uterus enlarged to 8 w
ks
4W
B
1day
PR
18
heterotopic
84
Subbam
m
al
38
57179
27.09.13
prim
i
30.07.13
59
P
10y
N
A
N
A
N
A
nil
M
TP pills
AM
,LAP
110/60
>120
6.9
N
D
D,T
FT,FF
P
P
IU
P,5w
ks,FL
N
D
ectopic 
1hr 15 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
cornua
2300
nil
4W
B,2FFP
2 days
PR
9
ectopic
85
m
ahesw
ari 
26
58390
04.10.13
prim
i
N
K
N
K
W
P
nil
N
A
N
A
N
A
nil
nil
LAP,BPV
120/80
106
10.6
4702
D,T
FT
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
40 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
300
nil
1W
B
nil
AB
7
ectopic
86
usha
28
58671
05.10.13
G
3P2L2
08.09.13
27
P
N
A
S
1Y
con
N
A
prev LSCS,tubal sx
LAP,BPV
100/70
76
11
N
D
nil
nil
N
N
D
EU
,Rt A. m
ass of 5.7cm
N
D
ectopic 
1 hr
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
fim
bria
50
adhesions
nil
nil
AB
7
ectopic
87
bharathy
29
60183
13.10.13
G
2P1L1
23.08.13
51
W
P
N
A
N
S
N
A
N
A
nil
nil
AM
,LAP,giddi
90/60
126
5.7
N
D
D
FT,FF
P
N
D
EU
,FL
N
D
ectopic 
1 hr
N
A
N
A
Lt partial salphingectom
y
R
Lt
Am
pulla
1350
nil
3 W
B
2 days
PR
9
ectopic
88
Rani
32
60298
14.10.13
prim
i
19.08.13
66
P
9 m
onths
N
A
N
A
N
A
nil
PID
AM
,LAP
100/70
78
10.6
N
D
T
FT
P
N
D
EU
,Lt A. m
ass,FL
N
D
ectopic 
2 hrs
N
A
N
A
Lt partial salphingectom
y
R
Lt
infundib
250
nil
nil
nil
AB
7
ectopic
89
Ram
ajeyam
32
61132
18.10.13
G
3P2L2
02.09.13
46
P
9m
S
10Y
con
N
A
prev LSCS,tubal sx
AM
90/60
72
12.7
N
D
nil
nil
N
N
D
EU
,Rt tubal ring, viable 7w
ks 
N
D
ectopic 
1 hr 10 m
in
N
A
N
A
B/L total salphingectom
y
tubal abortion
Rt
Am
pulla
100
nil
nil
nil
AB
7
ectopic
90
Ram
alakshm
i
20
60883
17.10.13
prim
i
05.09.13
42
P
6m
N
A
N
A
N
A
nil
nil
AM
,LAP,BPV
110/70
102
6.5
N
D
D,G
FT
P
N
D
EU
,FL
N
D
ectopic 
25 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
900
nil
2W
B
1 day
AB
7
ectopic
91
shoba
32
62414
24.10.13
G
2A1
31.08.13
54
P
5y
N
A
N
A 
N
A
nil
prev ectopic,PID,ART
AM
,LAP
110/70
84
10.8
N
D
G
FT
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
6 hrs
late diagnosis
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
500
Lt tube absent
1 PCV
nil
AB
7
ectopic
92
cherm
akani
26
62387
24.10.13
G
2P1L1
30.08.13
55
P
N
A
N
S
N
A
N
A
IU
CD
IU
CD
AM
120/60
88
9.6
2356
nil
nil
N
N
D
EU
,Rt A.sac , live 6w
ks fetus
N
D
ectopic 
1 hr
N
A
A
LSO
tubal abortion
Lt
Am
pulla
50
oozing from
 left ovary
nil
nil
AB
7
ectopic
93
Jasper pristilla
26
63081
28.10.13
G
3P2L2
05.09.13
53
P
N
A
N
S
N
A
N
A
nil
prev LSCS,M
TP pills
AM
,LAP,BPV
90/60
106
5.9
N
D
T
FT
P
N
D
EU
,FL
N
D
ectopic 
1 hr 30 m
in
N
A
N
A
B/L total salphingectom
y
R
Lt
isthm
us
900
nil
2W
B
nil
AB
7
ectopic
94
M
eenatchi
27
63421
30.10.13
G
3P1L1A1
24.09.13
36
W
P
N
A
N
S
N
A
N
A
B
abortion
LAP,BPV
110/70
100
8.5
N
D
T
FT
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
30 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
Am
pulla
200
endom
etriosis
1W
B
nil
AB
8
ectopic
95
Sudalai vadivu
27
63577
31.10.13
G
4P2L2A1
15.09.13
46
P
N
A
N
S
N
A
N
A
nil
 abortion,PID
AM
,LAP,BPV
120/80
92
10
N
D
T
FF
P
N
D
EU
,FL
N
D
ectopic 
35 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
850
nil
2W
B
nil
AB
8
ectopic
96
selvi
25
65019
07.11.13
prim
i
18.09.13
50
P
2.5y
N
A
N
A
N
A
nil
PID
AM
,LAP,BPV
120/80
78
12
39,738
T
nil
N
N
D
EU
,Rt ovary- 1cm
 follicle
N
D
ectopic 
7 days
late diagnosis
N
A
RSO
U
R
Rt
ovary
100
nil
nil
nil
AB
7
ectopic
97
m
aharasi
25
67969
21.11.13
G
2P1L1
05.10.13
47
P
N
A
N
S
N
A
N
A
LAM
prev LSCS
LAP,BPV
120/70
82
11
N
D
T
FT
N
N
D
EU
,Rt ovary - m
ulti follicles
N
D
ectopic 
4 hrs
late diagnosis
N
A
Rt total salphingectom
y
R
Rt
isthm
us
100
adhesions
nil
nil
AB
7
ectopic
98
am
utha
32
67976
21.11.13
G
4P2L2A1
12.10.13
40
W
P
N
A
N
S
N
A
N
A
IU
CD
abortion,IU
CD
AM
,LAP,BPV
130/70
80
11.8
440
nil
nil
N
N
D
EU
,sm
all Rt A. m
ass
N
D
ectopic 
2 days 
late diagnosis
A
M
edical, M
TX- m
ulti dose
U
R
Rt
N
A 
N
A
N
A
nil
nil
AB
12
ectopic
99
subha ozanna
29
69161
27.11.13
G
3P2L2
29.10.13
29
N
N
A
N
S
N
A
N
A
IU
CD
nil
LAP
140/70
102
9.3
N
D
nil
nil
N
N
D
IU
CD in situ,Rt A. m
ass,FL
N
D
ectopic 
30 m
in
N
A
N
A
RSO
R
Rt
ovary
1100
nil
2W
B
nil
AB
8
corpus luteal cyst
100
krishna rani
28
69969
01.12.13
G
2P1L1
09.10.13
53
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP,BPV
100/60
86
11.6
N
D
nil
nil
N
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
12 hrs
late diagnosis
N
A
RSO
R
Rt
Am
pulla
200
Rt tube &
ovary adherent
1W
B
nil
AB
8
ectopic
101
lakshm
i
28
70029
01.12.13
G
3P2L2
20.10.13
42
P
N
A
N
S
N
A
N
A
nil
prev LSCS,M
TP pills
AM
,LAP,giddi
80/60
126
8.8
N
D
D,T
FT
P
P
EU
,FL
N
D
ectopic 
30 m
in
N
A
N
A
B/L total salphingectom
y
R
Lt
isthm
us
2100
Rt fim
brial cyst
4W
B,4FFP,4PLTS
2 days
PR
8
ectopic
102
selvi
35
71782
10.12.13
G
3P2L2
10.11.13
30
P
N
A
N
S
11Y
LS
N
A
tubal surgery
LAP
100/60
82
11.5
N
D
nil
FF
N
N
D
EU
,Lt A. cyst,FL
CT-pelvic cyst,8 cm
ectopic 
24 hrs
late diagnosis
N
A
RSO
 &
 LSO
R
Rt
fim
bria
200
adhesions,Lt ovarian cyst
1W
B
nil
AB
8
ectopic
103
pathirakali
26
71637
09.12.13
G
4P2L2A1
05.10.13
65
P
N
A
S
1.5Y
con
N
A
abortion,LSCS,tubal sx
AM
,LAP,BPV
110/70
90
11.5
N
D
nil
nil
N
N
D
EU
,Lt A. m
ass,FL
N
D
ectopic 
40 m
in
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
fim
bria
200
E/O
 ST on Lt side
nil
nil
AB
8
ectopic
104
kulanthai
24
73310
17.12.13
prim
i
18.10.13
60
P
2y
N
A
N
A
N
A
nil
ovulation induction
AM
,LAP
80/40
>120,F
3.1
N
D
D,G
FF
P
N
D
EU
,Lt A. m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
cornua
2900
Lt corpus luteal cyst
5 W
B,3FFP
3 days
AB
10
ectopic
Sl.No
N
am
e
Age( in years)
I.P.No
D.O.A
Obstetric Code
LM
P
Period of 
Amenorrhoea (in 
Days)
UPT
Duration of 
Subfertility 
Sterlisation Status
Time Since ST 
(Years)
Method of ST
Other Contra 
Ceptive Use
R
isk Factors
Clinical 
Symptoms
B.P( in mmHg)
P.R( per minute)
Hb %
Sr.β HcG( M 
IU/ml)
P/A Findings
P/V Findings
Cervix Excitation 
Test
Culdocentesis
Ultrasound 
Findings
Additional Imaging 
Clinical Diagnosis
Time Interval 
Between Admission 
and Onset of 
definitive 
Treatment
Time Delay Due to
Medical 
Management 
Criteria 
Management
Ruptured (R) / 
Unruptured (UR)
Side
Site
Haemoperitoneum 
(in ml)
Other Findings
No.Of Units of 
Blood / Blood 
Products 
Transfusion
 ICU Care
Fever
Duration of 
Hospital Stay (in 
Days)
Final  
Diagnosis/HPE 
report 
105
kannika
30
73966
21.12.13
G
2P1L1
N
K
N
K
P
N
A
N
S
N
A
N
A
LAM
M
TP pills
LAP,BPV
110/70
98
10
N
D
T
FT
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
40m
in
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
Am
pulla
300
Rt tube &
ovary adherent
1W
B
nil
PR
7
ectopic
106
m
uthuselvi
35
74441
23.12.13
G
4P3L3
N
K
N
K
W
P
N
A
S
14Y
LS 
N
A
PID,tubal surgery
LAP,const,vom
it
90/70
80
11
508
nil
FF
N
N
D
EU
,Rt A.m
ass,FL
N
D
ectopic 
21 hrs
late diagnosis
N
A
B/L total salphingectom
y
R
Rt
isthm
us
700
E/O
 ST on Lt ,ovary cystic
1W
B
nil
AB
7
ectopic
107
Jeyalakshm
i
35
74440
23.12.13
prim
i
24.10.13
60
P
8y
N
A
N
A
N
A
nil
ART
AM
,LAP,BPV
100/70
88
9.8
N
D
D,T
FT
P
N
D
EU
,Rt A.m
ass,FL
N
D
ectopic 
45 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
isthm
us
1700
uterus &
bow
el adherent
3W
B
1 day
PR
9
ectopic
108
m
uppidathy
39
75756
31.12.13
G
7P6L2
15.11.12
46
W
P
N
A
S
10Y
PS
N
A
tubal surgery
AM
,LAP
120/80
72
11
N
D
D,T
FT
P
N
D
EU
,Lt A.m
ass,FL
N
D
ectopic 
45 m
in
N
A
N
A
LSO
,Rt salphingectom
y
R
Lt
ovary
250
E/O
 recanalisation on Lt 
1W
B 
nil
AB
8
corpus luteal cyst
109
subbulakshm
i
33
1307
08.01.14
G
2A1
22.11.13
47
P
14y
N
A
N
A
N
A
nil
O
vul.induction,recan.sx
AM
,LAP,BPV
110/70
82
9.4
N
D
D,T
FT
P
N
D
EU
,Lt A. ring,FL
N
D
ectopic 
1 hr 20 m
in
N
A
N
A
LSO
R
Lt
Am
pulla
550
bicorn uterus,adhesions
1W
B
nil
AB
8
ectopic
110
m
uthulakshm
i
21
75
01.01.14
prim
i
18.11.13
44
P
11m
N
A
N
A
N
A
nil
nil
AM
,LAP,BPV
120/70
76
14
872
nil
nil
N
N
D
EU
,Lt A. m
ass of 3.2 cm
doppler-Lt A.cyst,no flow
ectopic 
3 days
late diagnosis
A
M
edical, M
TX- m
ulti dose
U
R
Lt
N
A
N
A
N
A
nil
nil
AB
14
ectopic
111
m
urugeshw
ari
23
4485
25.01.14
G
3P1L1A1
17.11.13
69
P
N
A
N
S
N
A
N
A
nil
abortion,LSCS,PID
AM
,LAP,BPV
130/80
78
9.5
386
nil
nil
N
N
D
EU
,Lt A. m
ass, local fluid
N
D
ectopic 
48 hrs
late diagnosis
N
A
Lt partial salphingectom
y
tubal abortion
Lt
Am
pulla
75
Lt corpus luteal cyst
nil
nil
AB
7
ectopic
112
selvi
23
4867
28.01.14
G
3P2L2
N
K
N
K
P
N
A
S
3Y
con
N
A
prev LSCS,tubal sx
LAP
100/60
92
9.2
N
D
T
nil
N
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
35 m
in
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
cornua
1500
e/o ST on Lt side
2W
B
1day
AB
8
ectopic
113
sathya
26
6120
03.02.14
G
2P1L1
02.12.13
63
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,BPV,anuria
110/70
116
9.2
N
D
nil
nil
N
N
D
EU
,FL
N
D
ectopic 
40 m
in
N
A
N
A
LSO
R
Lt
cornua
1600
Adhesions
2 PCV
1 day
AB
8
ectopic
114
chandra
26
6473
05.02.14
G
3P2L2
N
K
N
K
P
N
A
S
7Y
PS
N
A
tubal surgery,PID
LAP,BPV
110/70
120
12
N
D
D,T
nil
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
1 hr
N
A
N
A
RSO
,Lt salphingectom
y
R
Rt
Am
pulla
650
e/o ST on Lt ,Rt ovary friable
2 W
B
nil
PR
8
ectopic
115
padm
a
29
6719
06.02.14
prim
i
19.12.13
49
P
7m
N
A
N
A
N
A
nil
PID
AM
,LAP,BPV
110/70
84
9.4
N
D
D,T
FT
P
N
D
EU
,Lt A. G
.sac of 1.6 cm
,no FP
N
D
ectopic 
4hrs 30 m
in
hCG
 report
A
M
edical, M
TX- m
ulti dose
U
R
Rt
N
A
N
A
N
A
nil
nil
AB
15
ectopic
116
parvathy
25
7197
09.02.14
G
2P1L1
17.11.13
84
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,BPV
100/60
92
4
N
D
nil
nil
N
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
38 hrs 
late diagnosis
N
A
rem
oval of Rt horn ectopic
R
Rt
Rt horn
1000
bicornuate uterus
2W
B,2PCV
2 days
AB
9
ectopic
117
eskkiam
m
al
30
8410
15.02.14
prim
i
24.12.13
53
P
4m
N
A
N
A
N
A
nil
nil
AM
,LAP,BPV
110/80
112
7.6
N
D
D,T
FT
P
P
EU
,Lt A. m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
Lt partial salphingectom
y
R
Lt
isthm
us
300
nil
2 W
B
nil
AB
8
ectopic
118
Ram
alakshm
i
29
13990
14.03.14
prim
i
05.02.14
37
P
6m
N
A
N
A
N
A
nil
nil
AM
,LAP
110/80
86
11
N
D
nil
nil
N
N
D
EU
,Rt A. G
.sac,FP 7 w
ks,FH +
N
D
ectopic 
1 hr 
N
A
N
A
Rt partial salphingectom
y
U
R
Rt
Am
pulla
nil
nil
nil
nil
AB
7
ectopic
119
shanthi
29
14199
16.03.14
G
3P1L1A1
03.02.14
41
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP
90/60
88
10.5
N
D
D
FF
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
45 m
in
N
A
N
A
RSO
R
Rt
infundib
900
Rt tube &
ovary adherent
2W
B
nil
AB
8
ectopic
120
sugirtha
30
15916
24.03.14
prim
i
21.01.14
62
P
10y
N
A
N
A
N
A
nil
ovulation induction
AM
,LAP
100/70
92
8.8
N
D
D,G
FT,FF
P
N
D
EU
,Rt A.m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
fim
bria
1450
active bleed from
 fim
bria
3 W
B
1 day
AB
8
ectopic
121
karpagavalli
25
16591
28.03.14
G
2A1
05.02.14
51
P
1y
N
A
N
A
N
A
nil
abortion
AM
,LAP
130/90
100
10.2
N
D
T
FT,FF
P
N
D
EU
,FL
N
D
ectopic 
1 hr
N
A
N
A
Lt partial salphingectom
y
R
Lt
Am
pulla
450
nil
1W
B
nil
AB
7
ectopic
122
lakshm
i
25
17284
31.03.14
G
3A2
N
K
N
K
P
2.5y
N
A
N
A
N
A
nil
abortions
LAP,anasarca
80/40
140,F
3.1
N
D
D,G
FT
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
20 m
in
N
A
N
A
Rt partial saphingectom
y
R
Rt
Am
pulla
2000
Rt ovary cystic
4W
B,4FFP
3 days,V
PR
10
ectopic
123
m
uniam
m
al
32
19677
13.04.14
G
2P1L1
28.02.14
44
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP,oliguria
80/60
124
6.3
N
D
D,T
FT
P
N
D
EU
,FL
N
D
ectopic 
3 hrs
sx side adm
n
N
A
Lt partial salphingectom
y
R
Lt
Am
pulla
1550
nil
4W
B
2 days
PR
9
ectopic
124
Ram
a prabha
33
22006
25.04.14
G
6P1L1A4
N
K
N
K
P
N
A
N
S
N
A
N
A
nil
 abortions,LSCS
LAP
150/90
82
10.9
N
D
T
FT,FF
P
N
D
EU
,Lt A.m
ass,FL
N
D
ectopic 
18 hrs
late diagnosis
N
A
LSO
R
Lt
fim
bria
550
Lt tube &
 ovary adherent
1W
B,1 PCV
nil
AB
8
ectopic
125
selvi
30
19723
13.04.14
G
4A3
03.03.14
41
P
10y
N
A
N
A
N
A
nil
abortions,prev ectopic
AM
,LAP,BPV
100/60
80
11
N
D
T
FT
P
N
D
EU
,Rt A. m
ass,FL
N
D
ectopic 
50 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
Am
pulla
250
Lt -only proxim
al tube +
1 W
B
nil
AB
7
ectopic
126
sudha
35
21300
21.04.14
prim
i
23.02.14
57
P
2y
N
A
N
A
N
A
nil
nil
AM
,LAP,giddi
100/70
92
8.1
N
D
D,G
FT
P
N
D
EU
,FL
N
D
ectopic 
40 m
in
N
A
N
A
Rt partial salphingectom
y
R
Rt
isthm
us
1600
nil
3 W
B
1 day
PR
9
ectopic
127
sukirtha
27
23663
03.05.14
G
2P1L1
22.03.14
42
W
P
N
A
N
S
N
A
N
A
nil
prev LSCS
AM
,LAP,vom
it
110/70
88
12
1126
nil
nil
N
N
D
EU
,Rt A. sac 1.3 cm
,Rt ovary cyst
N
D
ectopic 
12 hrs
late diagnosis
A
Rt total salphingectom
y,Rt ovarian cystectom
y
U
R
Rt
cornua
nil
com
p.Rt ov. cyst of 6x4cm
 
nil
nil
AB
8
ectopic
128
viji
27
24257
06.05.14
prim
i
04.03.14
63
P
3y
N
A
N
A
N
A
nil
ovulation induction
AM
,LAP,G
iddi
100/70
102
11
46193
nil
nil
N
P
EU
,FL
M
RI-Rt cornual ectopic
ectopic 
45 m
in
N
A
N
A
Rt total salphingectom
y
R
Rt
cornua
2500
active bleed at rupture site
3 W
B
2 days
PR
9
ectopic
129
thirum
alaiselvi
31
26157
15.05.14
G
3P2L1
27.03.14
49
P
N
A
N
S
N
A
N
A
nil
prev LSCS,PID
AM
,LAP,BPV
110/70
80
8.9
N
D
nil
nil
N
P
EU
,FL
N
D
ectopic 
3 hrs
late diagnosis
N
A
Lt partial salphingectom
y
tubal abortion
Lt
Am
pulla
50
nil
nil
nil
AB
7
ectopic
130
jeya lakshm
i
26
26805
19.05.14
prim
i
25.03.14
55
W
P
1.5y
N
A
N
A
N
A
nil
nil
AM
,BPV
120/80
90
12
956
nil
nil
N
N
D
EU
,Rt A.sac of 1cm
, FP+ ,no FH
N
D
ectopic 
1 day
late diagnosis
A
M
edical, M
TX- m
ulti dose
U
R
Rt
N
A
N
A
N
A
nil
nil
AB
15
ectopic
131
babitha
24
30213
03.06.14
G
3A2
20.04.14
44
P
2y
N
A
N
A
N
A
nil
 abortion,ovul.induction
AM
,LAP,BPV
110/70
120
7.4
N
D
D,T
FF
P
N
D
EU
,FL
N
D
ectopic 
30 m
in
N
A
N
A
Lt partial salphingectom
y
R
Lt
Am
pulla
800
nil
2W
B
nil
AB
8
ectopic
132
thangaselvi
25
30204
03.06.14
G
3P2L2
N
K
N
K
P
N
A
S
4Y
PS
N
A
tubal surgery
LAP.giddi
110/70
100
10
N
D
nil
FT
P
P
EU
,Rt A. m
ass,FL
N
D
ectopic 
7 hrs
IM
CU
 adm
n
N
A
RSO
,Lt salphingectom
y
R
Rt
ovary
1400
e/o ST on both sides
2W
B
1 day
PR
8
ectopic
133
nalvelkum
ari
24
32919
16.06.14
G
2P1L1
11.05.14
36
P
N
A
N
S
N
A
N
A
nil
prev LSCS
LAP,vom
it
110/70
122
11
N
D
D
FT,FF
P
P
EU
,Rt A. G
.sac , FP 7 w
ks,FH +
N
D
ectopic 
18 hrs 
sx side adm
n
N
A
Rt total salphingectom
y
R
Rt
fim
bria
800
nil
1W
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KEY TO MASTERCHART 
 
D.O.A    -  Date of admission 
I.P.NO   -  In patient number 
LMP      - Last menstrual period 
NK         -  Not known 
ND         -  Not done 
UPT      -  Urine pregnancy test 
P            -  Positive 
N           -  Negative 
WP       -  Weakly positive 
Y          -  Year 
m         -  month 
hr         -  hour 
min      -  minute 
S          -  Sterilised 
NS       -  Not Sterilised 
A         -  Applicable 
NA       -  Not applicable 
F          -  Feeble 
PR       -  Present 
AB      -  Absent 
Rt        -  Right 
Lt        -  Left 
R         -  Ruptured 
UR      -  Unruptured 
ST       -  Sterilisation 
LS        -  Laparoscopic sterilisation 
PS        - Puerperal sterilisation 
TAT    -  Total abdominal tubectomy 
Con     -  Concurrent sterilisation 
IUCD  -  Intrauterine contraceptive device 
EC      -  Emergency contraception 
COC   - Combined oral contraceptive 
POP    -  Progesterone only contraceptive 
B         -  Barrier method 
LAM   -  Lactational amenorrhoea 
MTP   -  Medical termination of pregnancy 
PID     -  Pelvic inflammatory disease 
ART   -  Artificial reproductive technique 
Sx        - Surgery 
LSCS  -  Lower segment caesarean section 
AM     -  Amenorrhoea 
LAP    -  Lower abdominal pain 
BPV    -  Bleeding per vaginum 
D         -  Abdominal Distension 
T          -  Abdominal tenderness 
FF       -  Forniceal fullness 
FT       -  Forniceal tenderness 
A.mass  -  Adnexal mass 
EU          -  Empty uterus 
FL          -  Free fluid 
G.sac           - Gestational sac 
Bicorn.ut    -  Bicornuate uterus 
FP              -  Fetal pole 
FH             -  Fetal heart 
RSO           -  Right salphingo oophorectomy 
LSO          - Left salphingo oophorectomy 
hCG          -  human chorionic gonadotropin 
Infundib  -  Infundibulum 
WB           -  Whole blood 
PCV        -  Packed cell volume 
PLTS       -  Platelets 
FFP         -  Fresh frozen plasma 
V             -  Ventilatory support 
 
